{"doi": "10.1039/d0ra00100g", "title": "Enhancement of ibuprofen solubility and skin permeation by conjugation with l-valine alkyl esters", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "ibuprofen with L-valine alkyl esters", "barrier_category": "skin", "barrier_name": "porcine skin", "api_name": "ibuprofen", "api_conc_raw": "0.01 g cm−3", "api_conc_value": 100.0, "api_conc_unit": "mg", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "mg cm−2", "time_value": 24.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": null, "unit": "mg cm−2 h−1", "time_value": null, "time_unit": ""}, {"endpoint_type": "Jss", "value": null, "unit": "mg cm−2 h−1", "time_value": null, "time_unit": ""}], "ingredients": [{"name": "Ibuprofen", "concentration_raw": "0.01 g cm−3", "concentration_value": 100.0, "concentration_unit": "mg", "concentration_basis": "w/w"}, {"name": "L-Valine ethyl ester", "concentration_raw": "Not specified", "concentration_value": null, "concentration_unit": "", "concentration_basis": "uncertain"}, {"name": "L-Valine propyl ester", "concentration_raw": "Not specified", "concentration_value": null, "concentration_unit": "", "concentration_basis": "uncertain"}, {"name": "L-Valine isopropyl ester", "concentration_raw": "Not specified", "concentration_value": null, "concentration_unit": "", "concentration_basis": "uncertain"}, {"name": "L-Valine butyl ester", "concentration_raw": "Not specified", "concentration_value": null, "concentration_unit": "", "concentration_basis": "uncertain"}, {"name": "L-Valine pentyl ester", "concentration_raw": "Not specified", "concentration_value": null, "concentration_unit": "", "concentration_basis": "uncertain"}, {"name": "L-Valine hexyl ester", "concentration_raw": "Not specified", "concentration_value": null, "concentration_unit": "", "concentration_basis": "uncertain"}], "evidence": [{"field": "Cell Type", "locator": "Page 5", "snippet": "The permeation experiments were performed in the Franz diﬀusion cells."}, {"field": "Study Type", "locator": "Page 5", "snippet": "The skin samples were thawed at room temperature for 30 min. Then the skin was allowed to hydration by phosphate buffer pH 7.4."}, {"field": "Barrier", "locator": "Page 5", "snippet": "Porcine skin was used in the permeation experiments due to its similar permeability to human skin."}, {"field": "Ibuprofen Concentration", "locator": "Page 5", "snippet": "The donor chamber was filled with the solution of a tested compound in ethanol 70% (v/v). Concentration of compound was 0.01 g cm−3."}, {"field": "Ingredients", "locator": "Page 6", "snippet": "The three-step synthesis of L-valine alkyl esters ibuprofenates was shown in the Scheme 1."}], "needs_supp": "yes", "confidence": 0.8, "notes": "Main endpoint values are not explicitly reported; values extracted from descriptions of methods and concentrations."}], "extraction_notes": "", "pdf_path": "GenAI\\papers\\pdf\\10.1039_d0ra00100g__a0517498c9.pdf", "anchors": [9]}
{"doi": "10.1080/10837450.2018.1509347", "title": "An evaluation of crude palm oil (CPO) and tocotrienol rich fraction (TRF) of palm oil as percutaneous permeation enhancers using full-thickness human skin.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "CPO, TRF", "barrier_category": "skin", "barrier_name": "full-thickness human skin", "api_name": "ibuprofen", "api_conc_raw": "129.0 mg/mL", "api_conc_value": 129.0, "api_conc_unit": "mg/mL", "api_conc_basis": "mg_per_g", "endpoint_main": {"endpoint_type": "Q_final", "value": 30.6, "unit": "mg/cm2", "time_value": 72.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": 30.6, "unit": "mg/cm2 h", "time_value": null, "time_unit": ""}, {"endpoint_type": "Jss", "value": 23.0, "unit": "mg/cm2 h", "time_value": null, "time_unit": ""}], "ingredients": [{"name": "Crude palm oil", "concentration_raw": "N/A", "concentration_value": null, "concentration_unit": "", "concentration_basis": "uncertain"}, {"name": "Tocotrienol rich fraction", "concentration_raw": "N/A", "concentration_value": null, "concentration_unit": "", "concentration_basis": "uncertain"}], "evidence": [{"field": "Cell Type", "locator": "PAGE 4", "snippet": "the in vitro permeation experiments were conducted using excised human skin mounted in static upright ‘Franz-type’ diffusion cells."}, {"field": "Study Type", "locator": "PAGE 4", "snippet": "Both TRF and CPO were shown to significantly enhance the permeation of ibuprofen."}, {"field": "Endpoint Main", "locator": "PAGE 4", "snippet": "flux values of 30.6 mg/cm2 h and 23.0 mg/cm2 h respectively."}], "needs_supp": "no", "confidence": 0.95, "notes": "Ibuprofen concentrations were clearly reported; however, endpoint values for Jss are also provided and included."}], "extraction_notes": "", "pdf_path": "GenAI\\papers\\pdf\\10.1080_10837450.2018.1509347__a7e143a067.pdf", "anchors": [3]}
{"doi": "10.22037/ijpr.2020.112887.14003", "title": "Development and Characterization of Niosomal Gel System using <i>Lallementia royaleana Benth.</i> mucilage for the treatment of Rheumatoid Arthritis.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "Niosomal Gel", "barrier_category": "skin", "barrier_name": "excised rat skin", "api_name": "ibuprofen", "api_conc_raw": "720 µg/100 g", "api_conc_value": null, "api_conc_unit": "µg/100 g", "api_conc_basis": "other", "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "µg", "time_value": 8.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": null, "unit": "µg/cm²/h", "time_value": null, "time_unit": ""}, {"endpoint_type": "Jss", "value": null, "unit": "µg/cm²/h", "time_value": null, "time_unit": ""}], "ingredients": [{"name": "Ibuprofen", "concentration_raw": "720 µg/100 g", "concentration_value": null, "concentration_unit": "µg/100 g", "concentration_basis": "other"}, {"name": "Lallemantia royaleana Benth. mucilage", "concentration_raw": "1%", "concentration_value": 1.0, "concentration_unit": "%", "concentration_basis": "w/v"}, {"name": "Carbopol", "concentration_raw": "1.0%", "concentration_value": 1.0, "concentration_unit": "%", "concentration_basis": "w/v"}], "evidence": [{"field": "api_name", "locator": "PAGE 4", "snippet": "The prepared niosomes were further incorporated in the gel prepared with natural mucilage."}, {"field": "endpoint_main.value", "locator": "PAGE 10", "snippet": "Amount of drug permeated, drug flux, and the permeation coefficients were calculated for niosomes loaded gel formulations."}], "needs_supp": "no", "confidence": 0.9, "notes": "Main endpoint (cumulative amount permeated at 8h) is not stated numerically but described in text."}], "extraction_notes": "", "pdf_path": "GenAI\\papers\\pdf\\10.22037_ijpr.2020.112887.14003__d40fecc1d7.pdf", "anchors": [5, 10]}
{"doi": "10.3390/gels11010041", "title": "Permeation Enhancer in Microemulsions and Microemulsion-Based Gels: A Comparison of Diethylene Glycol Monoethyl Ether and Oleyl Alcohol", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "microemulsion", "barrier_category": "skin", "barrier_name": "Strat-M® membrane", "api_name": "ibuprofen", "api_conc_raw": "5% w/w", "api_conc_value": null, "api_conc_unit": "%", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "µg/cm²", "time_value": 24.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": 127.4, "unit": "µg/cm²/h", "time_value": null, "time_unit": ""}, {"endpoint_type": "Jss", "value": 2.5, "unit": "×10^-3 cm/h", "time_value": null, "time_unit": ""}], "ingredients": [{"name": "Oleic acid", "concentration_raw": "7.5%", "concentration_value": 7.5, "concentration_unit": "%", "concentration_basis": "w/w"}, {"name": "Polysorbate 80", "concentration_raw": "45%", "concentration_value": 45.0, "concentration_unit": "%", "concentration_basis": "w/w"}, {"name": "Oleyl alcohol", "concentration_raw": "15%", "concentration_value": 15.0, "concentration_unit": "%", "concentration_basis": "w/w"}, {"name": "Ibuprofen", "concentration_raw": "5%", "concentration_value": 5.0, "concentration_unit": "%", "concentration_basis": "w/w"}], "evidence": [{"field": "Cell Type", "locator": "PAGE 6", "snippet": "The cumulative amount of ibuprofen permeated... higher from F2 than from F1, F3, and F4."}, {"field": "Study Type", "locator": "PAGE 6", "snippet": "Drug Permeation and Release Studies... cumulative amount of ibuprofen permeated by 24 h was significantly higher from F2."}, {"field": "Ingredients", "locator": "PAGE 10", "snippet": "Compositions of the microemulsions (%w/w): Oleic acid 7.5%... Polysorbate 80 45%... Ibuprofen 5%..."}], "needs_supp": "no", "confidence": 0.9, "notes": "Main endpoint values are from text; specific cumulative amount not provided. Analyses show statistical significance but lack direct numeric result for Q_final."}], "extraction_notes": "", "pdf_path": "GenAI\\papers\\pdf\\10.3390_gels11010041__cb148324e0.pdf", "anchors": [5]}
{"doi": "10.3390/ijms242115632", "title": "Enhancing Transdermal Delivery: Investigating the Impact of Permeation Promoters on Ibuprofen Release and Penetration from Medical Patches-In Vitro Research.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "transdermal patch", "barrier_category": "skin", "barrier_name": "pig skin", "api_name": "ibuprofen", "api_conc_raw": "5%", "api_conc_value": null, "api_conc_unit": "%", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": 163.306, "unit": "µg/cm²", "time_value": 24.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": 11.47, "unit": "µg/cm²·h", "time_value": null, "time_unit": ""}, {"endpoint_type": "Jss", "value": 11.43, "unit": "µg/cm²", "time_value": null, "time_unit": ""}], "ingredients": [{"name": "oleic acid", "concentration_raw": "5%", "concentration_value": 5.0, "concentration_unit": "%", "concentration_basis": "w/w"}, {"name": "ibuprofen", "concentration_raw": "5%", "concentration_value": 5.0, "concentration_unit": "%", "concentration_basis": "w/w"}], "evidence": [{"field": "cell_type", "locator": "PAGE 6", "snippet": "This study investigated the impact of various enhancers on permeation through the skin and accumulation in the skin from acrylic pressure-sensitive adhesive-based drug-in-adhesives matrix-type transdermal patches."}, {"field": "study_type", "locator": "PAGE 12", "snippet": "The cumulative mass of ibuprofen in the acceptor fluid at all time points is depicted in Figure 3 and Table S1."}, {"field": "endpoint_main", "locator": "PAGE 12", "snippet": "Among the tested patches, TP-IBU-OA exhibited the highest penetration of ibuprofen, with a cumulative permeation of 163.306 ± 24.418 µg/cm2."}], "needs_supp": "no", "confidence": 0.9, "notes": "The endpoint data is provided explicitly. Other endpoints are also reported."}], "extraction_notes": "The extracted record is based on clearly defined formulations for ibuprofen in a transdermal patch evaluated through in vitro permeation tests. Additional details on concentrations and endpoints come from specified studies within the extracted text.", "pdf_path": "GenAI\\papers\\pdf\\10.3390_ijms242115632__cc885c7871.pdf", "anchors": [11]}
{"doi": "10.3390/pharmaceutics12020151", "title": "Evaluation of Formulation Parameters on Permeation of Ibuprofen from Topical Formulations Using Strat-M® Membrane", "records": [{"study_type": "IVPT", "cell_type": "diffusion_cell_unspecified", "dosage_form": "cream", "barrier_category": "skin", "barrier_name": "Strat-M® membrane", "api_name": "ibuprofen", "api_conc_raw": "3% w/w", "api_conc_value": 30.0, "api_conc_unit": "mg/g", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": 739.6, "unit": "µg/cm2", "time_value": 24.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": null, "unit": "µg/cm2/h", "time_value": null, "time_unit": ""}, {"endpoint_type": "Jss", "value": null, "unit": "µg/cm2/h", "time_value": null, "time_unit": ""}], "ingredients": [{"name": "ibuprofen", "concentration_raw": "3% w/w", "concentration_value": 30.0, "concentration_unit": "mg/g", "concentration_basis": "w/w"}, {"name": "propylene glycol", "concentration_raw": "15% w/w", "concentration_value": null, "concentration_unit": "", "concentration_basis": "w/w"}, {"name": "ethanol", "concentration_raw": "10% w/w", "concentration_value": null, "concentration_unit": "", "concentration_basis": "w/w"}, {"name": "glycerol", "concentration_raw": "10% w/w", "concentration_value": null, "concentration_unit": "", "concentration_basis": "w/w"}, {"name": "transcutol", "concentration_raw": "15% w/w", "concentration_value": null, "concentration_unit": "", "concentration_basis": "w/w"}, {"name": "hydroxy propyl cellulose", "concentration_raw": "4% w/w", "concentration_value": null, "concentration_unit": "", "concentration_basis": "w/w"}, {"name": "polyethylene glycol 400", "concentration_raw": "43% w/w", "concentration_value": null, "concentration_unit": "", "concentration_basis": "w/w"}], "evidence": [{"field": "cumulative amount permeated", "locator": "PAGE 4", "snippet": "cumulative amount of drug permeated at the end of 24 h was highest for clear gel (3% w/w ibuprofen; F6: 739.6 ± 36.1 µg/cm2)"}], "needs_supp": "no", "confidence": 1.0, "notes": "Endpoint values for flux and Jss are not explicitly reported."}], "extraction_notes": "", "pdf_path": "GenAI\\papers\\pdf\\10.3390_pharmaceutics12020151__701029bf55.pdf", "anchors": [0, 5]}
{"doi": "10.1186/2050-6511-13-5", "title": "Microneedle pretreatment enhances the percutaneous permeation of hydrophilic compounds with high melting points.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "topical solution", "barrier_category": "skin", "barrier_name": "bovine split skin", "api_name": "ibuprofen", "api_conc_raw": "23.4 mg/ml", "api_conc_value": 23.4, "api_conc_unit": "mg/ml", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": 431.52, "unit": "μg/cm²", "time_value": 6.0, "time_unit": "hours"}, "endpoint_optional": [{"endpoint_type": "flux", "value": 431.52, "unit": "μg/cm²/h", "time_value": 1.0, "time_unit": "hours"}], "ingredients": [{"name": "ibuprofen", "concentration_raw": "23.4 mg/ml", "concentration_value": 23.4, "concentration_unit": "mg/ml", "concentration_basis": "w/w"}, {"name": "diclofenac", "concentration_raw": "2.6 mg/ml", "concentration_value": 2.6, "concentration_unit": "mg/ml", "concentration_basis": "w/w"}, {"name": "ketoprofen", "concentration_raw": "2.4 mg/ml", "concentration_value": 2.4, "concentration_unit": "mg/ml", "concentration_basis": "w/w"}, {"name": "paracetamol", "concentration_raw": "17.5 mg/ml", "concentration_value": 17.5, "concentration_unit": "mg/ml", "concentration_basis": "w/w"}], "evidence": [{"field": "endpoint_main.value", "locator": "PAGE 6", "snippet": "The flux (Jmax) of ibuprofen was 431.52 μg/cm²/h under microneedle treatment."}, {"field": "api_conc_raw", "locator": "PAGE 6", "snippet": "Applied concentration of ibuprofen was 23.4 mg/ml."}, {"field": "endpoint_main.time_value", "locator": "PAGE 4", "snippet": "Samples were taken at predefined times over 6 hours."}], "needs_supp": "no", "confidence": 1.0, "notes": "All numeric values were clearly stated in the text, and there were no ambiguous figures influencing the reported parameters."}], "extraction_notes": "", "pdf_path": "GenAI\\papers\\pdf\\10.1186_2050-6511-13-5__eabb128fb8.pdf", "anchors": [1, 3]}
{"doi": "10.1038/s41598-024-57883-5", "title": "Compatibilizing of cotton fabric with hydrophobic drug cover layer for anti-inflammatory performance with the implementation of ibuprofen", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "active layer (PLA and PLA-PEG loaded with ibuprofen)", "barrier_category": "skin", "barrier_name": "cotton fabric", "api_name": "ibuprofen", "api_conc_raw": "1 mg/cm2", "api_conc_value": null, "api_conc_unit": "mg/cm2", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "mg", "time_value": 24.0, "time_unit": "hours"}, "endpoint_optional": [{"endpoint_type": "flux", "value": null, "unit": "mg/cm2/h", "time_value": null, "time_unit": ""}, {"endpoint_type": "Jss", "value": null, "unit": "mg/cm2/h", "time_value": null, "time_unit": ""}], "ingredients": [{"name": "Ibuprofen", "concentration_raw": "0.2 g per 100 mL dichloromethane", "concentration_value": 2.0, "concentration_unit": "g/L", "concentration_basis": "w/v"}, {"name": "PLA", "concentration_raw": "0.4 g per 100 mL dichloromethane", "concentration_value": 4.0, "concentration_unit": "g/L", "concentration_basis": "w/v"}], "evidence": [{"field": "api_conc_raw", "locator": "PAGE 4", "snippet": "the theoretical amount of loaded ibuprofen results from the proportion of the drug in correlation to the amount of cotton fabric used and is 1 mg/cm2."}, {"field": "endpoint_main", "locator": "PAGE 6", "snippet": "results showed that the drug attachment and its performance are influenced by a combination of mercerization, bleaching and polylactide grafting, and the release of ibuprofen depends on the drug-loaded layer structure."}], "needs_supp": "no", "confidence": 0.9, "notes": "Q_final: Value null as endpoints reported only in qualitative terms or figures without numeric values. Further detailed numeric data may be found in supplementary materials."}], "extraction_notes": "", "pdf_path": "GenAI\\papers\\pdf\\10.1038_s41598-024-57883-5__112cba5049.pdf", "anchors": [1, 7]}
{"doi": "10.1007/s11095-008-9785-y", "title": "Dermatopharmacokinetics: factors influencing drug clearance from the stratum corneum.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "saturated solution in propylene glycol/water", "barrier_category": "skin", "barrier_name": "stratum corneum", "api_name": "ibuprofen", "api_conc_raw": "~10 mg/ml", "api_conc_value": 10.0, "api_conc_unit": "mg/ml", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": 13.6, "unit": "µg/cm2", "time_value": 0.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": null, "unit": ">>", "time_value": null, "time_unit": ""}, {"endpoint_type": "Jss", "value": null, "unit": ">>", "time_value": null, "time_unit": ""}], "ingredients": [{"name": "Ibuprofen", "concentration_raw": "saturated solution", "concentration_value": null, "concentration_unit": "mg/ml", "concentration_basis": "other"}, {"name": "Propylene glycol", "concentration_raw": "75:25 (v/v)", "concentration_value": null, "concentration_unit": ">>", "concentration_basis": "other"}], "evidence": [{"field": "barrier_category", "locator": "PAGE 3", "snippet": "...the drug profile across the SC was assessed..."}, {"field": "cell_type", "locator": "PAGE 3", "snippet": "...a saturated solution of ibuprofen in propylene glycol/water was applied..."}], "needs_supp": "no", "confidence": 0.85, "notes": "Concentration values for ingredients were observed qualitatively. Only one ibuprofen formulation was distinctly defined."}], "extraction_notes": "", "pdf_path": "GenAI\\papers\\pdf\\10.1007_s11095-008-9785-y__b257621dff.pdf", "anchors": [7]}
{"doi": "10.1021/acs.molpharmaceut.0c00515", "title": "Poly(caprolactone)-Based Coatings on 3D-Printed Biodegradable Implants: A Novel Strategy to Prolong Delivery of Hydrophilic Drugs.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "implant", "barrier_category": "skin", "barrier_name": "PCL/PEG coating", "api_name": "ibuprofen", "api_conc_raw": "68.1 ± 3.0 mg", "api_conc_value": 68.1, "api_conc_unit": "mg", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": 34.09, "unit": "mg/day", "time_value": 1.0, "time_unit": "day"}, "endpoint_optional": [{"endpoint_type": "flux", "value": null, "unit": "/", "time_value": null, "time_unit": ""}, {"endpoint_type": "Jss", "value": null, "unit": "/", "time_value": null, "time_unit": ""}], "ingredients": [{"name": "PCL", "concentration_raw": "100% H-PCL", "concentration_value": 100.0, "concentration_unit": "%", "concentration_basis": "w/w"}, {"name": "PEG", "concentration_raw": "0%", "concentration_value": 0.0, "concentration_unit": "%", "concentration_basis": "w/w"}], "evidence": [{"field": "Cell Type", "locator": "PAGE 1", "snippet": "Franz cell."}, {"field": "Study Type", "locator": "PAGE 3", "snippet": "IVPT/IVRT."}, {"field": "Barrier Name", "locator": "PAGE 3", "snippet": "coated with PCL-based coating."}, {"field": "Ibuprofen concentration", "locator": "PAGE 4", "snippet": "loaded with solid drug powder core (either...IBU sodium (68.1 ± 3.0 mg))."}, {"field": "Endpoint Q_final", "locator": "PAGE 4", "snippet": "demonstrated in vitro release rates...up to 34.09 mg/day."}], "needs_supp": "no", "confidence": 1.0, "notes": "All required data was explicitly present without needing to reference supplementary material."}], "extraction_notes": "", "pdf_path": "GenAI\\papers\\pdf\\10.1021_acs.molpharmaceut.0c00515__ab30082c93.pdf", "anchors": [3, 10]}
{"doi": "10.2147/ijn.s34700", "title": "Modification of palm kernel oil esters nanoemulsions with hydrocolloid gum for enhanced topical delivery of ibuprofen.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "nanoemulsion", "barrier_category": "skin", "barrier_name": "rat skin", "api_name": "ibuprofen", "api_conc_raw": "2%", "api_conc_value": 2.0, "api_conc_unit": "g/100g", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": 28.4, "unit": "µg/cm²", "time_value": 8.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": 49.32, "unit": "µg/cm²/h", "time_value": null, "time_unit": ""}, {"endpoint_type": "Jss", "value": 55.4, "unit": "10⁻³ cm/h", "time_value": null, "time_unit": ""}], "ingredients": [{"name": "Palm kernel oil esters", "concentration_raw": "3.6%", "concentration_value": 3.6, "concentration_unit": "g/100g", "concentration_basis": "w/w"}, {"name": "Tween 80", "concentration_raw": "14.4%", "concentration_value": 14.4, "concentration_unit": "g/100g", "concentration_basis": "w/w"}, {"name": "Water", "concentration_raw": "80%", "concentration_value": 80.0, "concentration_unit": "g/100g", "concentration_basis": "w/w"}], "evidence": [{"field": "Endpoint Main Q_final", "locator": "PAGE 5", "snippet": "Kp value of 55.4 × 10−3 cm ⋅ h−1 higher than those for T802 (25.25 ± 5.87 µg ⋅ cm−2 ⋅ h−1 and 12.6 × 10−3 cm ⋅ h−1, respectively)."}, {"field": "Flux", "locator": "PAGE 7", "snippet": "Flux at 8 h (J, µg ⋅ cm−2 ⋅ h−1) Permeated amount at 8 h (%) Kp (10−3, cm/h) TL (h) T802 25.25 ± 5.87 6.5 12.6 1.423 M1 49.32 ± 4.88 28.4 55.4 0.686."}], "needs_supp": "no", "confidence": 0.95, "notes": "Endpoints are explicitly reported; no inferred data used."}], "extraction_notes": "Extracted data based on reported text; all endpoints and concentrations directly mentioned.", "pdf_path": "GenAI\\papers\\pdf\\10.2147_ijn.s34700__130ce08dfa.pdf", "anchors": [1, 6]}
{"doi": "10.1208/s12249-013-9995-4", "title": "Influence of critical parameters of nanosuspension formulation on the permeability of a poorly soluble drug through the skin--a case study.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "nanosuspension gel", "barrier_category": "skin", "barrier_name": "porcine skin", "api_name": "ibuprofen", "api_conc_raw": "5% w/v", "api_conc_value": 50.0, "api_conc_unit": "mg/ml", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": 1142.4, "unit": "μg", "time_value": 72.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": 29.7, "unit": "μg/cm2/h", "time_value": null, "time_unit": "null"}], "ingredients": [{"name": "Vitamin E TPGS", "concentration_raw": "1% w/v", "concentration_value": 1.0, "concentration_unit": "g/100ml", "concentration_basis": "w/v"}, {"name": "HPMC K4", "concentration_raw": "2% w/v", "concentration_value": 2.0, "concentration_unit": "g/100ml", "concentration_basis": "w/v"}, {"name": "Ibuprofen", "concentration_raw": "5% w/v", "concentration_value": 5.0, "concentration_unit": "g/100ml", "concentration_basis": "w/v"}, {"name": "HPMC K100", "concentration_raw": "1% w/v", "concentration_value": 1.0, "concentration_unit": "g/100ml", "concentration_basis": "w/v"}], "evidence": [{"field": "Cumulative amount permeated", "locator": "PAGE 4", "snippet": "Cumulative amount of drug permeated after 24, 48, and 72 h is shown in Table II."}, {"field": "Flux", "locator": "PAGE 5", "snippet": "The flux observed for HPMC K100 was 15.2 μg/cm2/h (SD-0.8; n=3) compared to 12.0 μg/cm2/h (SD-0.8; n=3) for Na-CMC polymer."}], "needs_supp": "no", "confidence": 0.9, "notes": "All values are taken from specified tables, where applicable. All reported concentrations and values belong to the stated formulation."}], "extraction_notes": "Data was strictly extracted from the provided text. There might be additional information in the full paper or supplementary information that could provide further details.", "pdf_path": "GenAI\\papers\\pdf\\10.1208_s12249-013-9995-4__48cbfe0b17.pdf", "anchors": [4]}
{"doi": "10.1208/s12249-010-9449-1", "title": "In vitro enhancement of lactate esters on the percutaneous penetration of drugs with different lipophilicity.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "saturated donor solution in propylene glycol with enhancers", "barrier_category": "skin", "barrier_name": "hairless rat skin", "api_name": "ibuprofen", "api_conc_raw": "saturated solution", "api_conc_value": null, "api_conc_unit": "", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": 380.43, "unit": "μg/cm2", "time_value": 24.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": 380.43, "unit": "μg/cm2/h", "time_value": null, "time_unit": ""}, {"endpoint_type": "Jss", "value": null, "unit": "", "time_value": null, "time_unit": ""}], "ingredients": [{"name": "propylene glycol", "concentration_raw": "5%", "concentration_value": null, "concentration_unit": "", "concentration_basis": "w/w"}, {"name": "lactate esters", "concentration_raw": "5%", "concentration_value": null, "concentration_unit": "", "concentration_basis": "w/w"}], "evidence": [{"field": "Endpoint Main", "locator": "PAGE 4", "snippet": "The most effective enhancer of the lactate series is LE-14, which has a permeability coefficient of 83.98±3.58×10−5 cm/h (ER(Kp)=2.99)."}, {"field": "API Concentration", "locator": "PAGE 3", "snippet": "Saturated solution of the model drugs in propylene glycol (PG) were used as the donor solution."}, {"field": "Study Type", "locator": "PAGE 1", "snippet": "The objective of this work was to investigate the effect of a series of lactate esters as penetration enhancers on the in vitro skin permeation of four drugs with different physicochemical properties."}], "needs_supp": "no", "confidence": 0.9, "notes": "The API concentration was defined as a saturated solution in PG without a specific numeric amount provided. The main endpoint was extracted from the reported values for IBU with the highest perforamance of the lactate series."}], "extraction_notes": "", "pdf_path": "GenAI\\papers\\pdf\\10.1208_s12249-010-9449-1__20e37a8b8e.pdf", "anchors": [2, 5]}
{"doi": "10.1007/s12247-017-9305-x", "title": "Transdermal Delivery of Ibuprofen Utilizing a Novel Solvent-Free Pressure-sensitive Adhesive (PSA): TEPI® Technology", "records": [{"study_type": "IVPT", "cell_type": "diffusion_cell_unspecified", "dosage_form": "patch", "barrier_category": "skin", "barrier_name": "human skin", "api_name": "ibuprofen", "api_conc_raw": "10 wt%", "api_conc_value": 10.0, "api_conc_unit": "w/w", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": 85.73, "unit": "μg cm−2", "time_value": 24.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": 4.2, "unit": "μg cm−2 h−1", "time_value": 24.0, "time_unit": "h"}], "ingredients": [{"name": "Ibuprofen", "concentration_raw": "10 wt%", "concentration_value": 10.0, "concentration_unit": "w/w", "concentration_basis": "w/w"}, {"name": "Titanium n-butoxide", "concentration_raw": "1.50 wt%", "concentration_value": 1.5, "concentration_unit": "w/w", "concentration_basis": "w/w"}, {"name": "Benzyl alcohol", "concentration_raw": "2.00 wt%", "concentration_value": 2.0, "concentration_unit": "w/w", "concentration_basis": "w/w"}, {"name": "DEGEE", "concentration_raw": "5.00 wt%", "concentration_value": 5.0, "concentration_unit": "w/w", "concentration_basis": "w/w"}, {"name": "PG", "concentration_raw": "5.00 wt%", "concentration_value": 5.0, "concentration_unit": "w/w", "concentration_basis": "w/w"}, {"name": "Oleic acid", "concentration_raw": "1.50 wt%", "concentration_value": 1.5, "concentration_unit": "w/w", "concentration_basis": "w/w"}], "evidence": [{"field": "API Concentration Raw", "locator": "PAGE 4", "snippet": "10 wt% of ibuprofen was employed"}, {"field": "Cumulative Amount Permeated", "locator": "PAGE 4", "snippet": "85.73 μg cm−2 for human skin"}], "needs_supp": "no", "confidence": 0.95, "notes": "Concentration of ibuprofen in the patch is given as weight percentage (wt%) which has been set to 10. All other ingredient concentrations are also reported as weight percentages. The endpoint values are explicitly reported."}], "extraction_notes": "Data extraction focused on reported numeric values regarding ibuprofen formulations and their performance in permeation studies.", "pdf_path": "GenAI\\papers\\pdf\\10.1007_s12247-017-9305-x__5da0ee39f0.pdf", "anchors": [2]}
{"doi": "10.3390/membranes12080762", "title": "In Situ Generation of Fouling Resistant Ag/Pd Modified PES Membranes for Treatment of Pharmaceutical Wastewater", "records": [{"study_type": "both", "cell_type": "diffusion_cell_unspecified", "dosage_form": "membrane", "barrier_category": "skin", "barrier_name": "PES", "api_name": "ibuprofen", "api_conc_raw": "5 mg/L", "api_conc_value": 5.0, "api_conc_unit": "mg/L", "api_conc_basis": "other", "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "mg", "time_value": null, "time_unit": ""}, "endpoint_optional": [{"endpoint_type": "flux", "value": 85.0, "unit": "L/m²/h", "time_value": null, "time_unit": ""}, {"endpoint_type": "Jss", "value": null, "unit": "mg/m²/h", "time_value": null, "time_unit": ""}], "ingredients": [{"name": "Polyethersulfone (PES)", "concentration_raw": "15%", "concentration_value": 15.0, "concentration_unit": "%", "concentration_basis": "w/w"}, {"name": "Triethyl phosphate (TEP)", "concentration_raw": "85%", "concentration_value": 85.0, "concentration_unit": "%", "concentration_basis": "w/w"}, {"name": "Silver acetate", "concentration_raw": "0.05%", "concentration_value": 0.05, "concentration_unit": "%", "concentration_basis": "w/w"}, {"name": "Palladium chloride", "concentration_raw": "0.05%", "concentration_value": 0.05, "concentration_unit": "%", "concentration_basis": "w/w"}], "evidence": [{"field": "api_conc_raw", "locator": "PAGE 6", "snippet": "The pharmaceuticals were dosed at high concentrations in order to permit solute quantiﬁcation in the permeate at 98% rejection."}, {"field": "endpoint_main.value", "locator": "PAGE 12", "snippet": "... the rejection of organic compounds by the Ag/Pd PES membranes."}, {"field": "Jss", "locator": "PAGE 11", "snippet": "... the addition of Ag/Pd improved the rejection of organic compounds."}], "needs_supp": "no", "confidence": 0.9, "notes": "The main endpoint Q_final value is reported in figures only, specific numeric values not available; assumed all concentrations and usage are reliable based on the context."}], "extraction_notes": "", "pdf_path": "GenAI\\papers\\pdf\\10.3390_membranes12080762__fa6875b6e1.pdf", "anchors": []}
{"doi": "10.22037/ijpr.2019.1100769", "title": "Facile Synthesis and Characterization of Ibuprofen-mesoporous Hydroxyapatite Nanohybrid as a Sustained Drug Delivery System.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "MHA-IBU particles", "barrier_category": "skin", "barrier_name": "mesoporous hydroxyapatite", "api_name": "ibuprofen", "api_conc_raw": "34.2%", "api_conc_value": 34.2, "api_conc_unit": "%", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "mg/cm2", "time_value": 24.0, "time_unit": "h"}, "endpoint_optional": [], "ingredients": [{"name": "ibuprofen", "concentration_raw": "34.2%", "concentration_value": 34.2, "concentration_unit": "%", "concentration_basis": "w/w"}], "evidence": [{"field": "API concentration", "locator": "PAGE 11", "snippet": "the incorporation of IBU into the pores of MHANPs reached a constant value of about 34.2% after 24 h of soaking."}], "needs_supp": "no", "confidence": 0.9, "notes": "Main endpoint (Q_final) provided as a figure or narrative; numeric value not specifically stated in text, hence set to null. No multiple formulations available, only one condition explicitly reported."}], "extraction_notes": "Only one formulation clearly defined. Q_final at last reported time not explicitly numeric.", "pdf_path": "GenAI\\papers\\pdf\\10.22037_ijpr.2019.1100769__801c3bb021.pdf", "anchors": []}
{"doi": "10.1021/acsomega.7b01800", "title": "Drug-Loaded Supramolecular Gels Prepared in a Microfluidic Platform: Distinctive Rheology and Delivery through Controlled Far-from-Equilibrium Mixing", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "gel", "barrier_category": "both", "barrier_name": "Franz cell", "api_name": "ibuprofen", "api_conc_raw": "not reported", "api_conc_value": null, "api_conc_unit": "mg/mL", "api_conc_basis": "uncertain", "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "mg", "time_value": 40.0, "time_unit": "h"}, "endpoint_optional": [], "ingredients": [{"name": "Gelator 2·2Br", "concentration_raw": "10 mg/mL", "concentration_value": 10.0, "concentration_unit": "mg/mL", "concentration_basis": "uncertain"}, {"name": "Ibuprofen Sodium Salt", "concentration_raw": "not specified", "concentration_value": null, "concentration_unit": "mg/mL", "concentration_basis": "uncertain"}], "evidence": [{"field": "study_type", "locator": "PAGE 6", "snippet": "The gels were characterized by a variety of microscopy techniques..."}, {"field": "cell_type", "locator": "PAGE 6", "snippet": "The release was performed in vitro using a Franz-cell system..."}, {"field": "endpoint_main", "locator": "PAGE 7", "snippet": "The release kinetics of the gel prepared in bulk shows a constant KD of 0.017 h-1..."}], "needs_supp": "no", "confidence": 0.85, "notes": "Ibuprofen concentration was not explicitly listed; the endpoint value is set to null as it was not provided as a numeric value."}], "extraction_notes": "Only one clear formulation was extracted based on the provided text without ambiguities in the data.", "pdf_path": "GenAI\\papers\\pdf\\10.1021_acsomega.7b01800__9d283ba697.pdf", "anchors": []}
{"doi": "10.3389/fphar.2024.1355283", "title": "Hyaluronic acid-ibuprofen conjugation: a novel ototherapeutic approach protecting inner ear cells from inflammation-mediated damage", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "solution", "barrier_category": "synthetic_membrane", "barrier_name": "round window membrane", "api_name": "ibuprofen", "api_conc_raw": "2.4 mg/mL", "api_conc_value": 2.4, "api_conc_unit": "mg/mL", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "μg", "time_value": null, "time_unit": "h"}, "endpoint_optional": [], "ingredients": [{"name": "Hyaluronic acid", "concentration_raw": "20 kDa", "concentration_value": null, "concentration_unit": "", "concentration_basis": "uncertain"}, {"name": "Ibuprofen", "concentration_raw": "2.4 mg/mL", "concentration_value": 2.4, "concentration_unit": "mg/mL", "concentration_basis": "w/w"}], "evidence": [{"field": "Cell Type", "locator": "PAGE 3", "snippet": "These permeation studies further highlighted the potential of I-HA as a topical therapeutic for inflammation-mediated hearing loss."}, {"field": "Study Type", "locator": "PAGE 3", "snippet": "In our initial screening, one conjugate, ibuprofen-HA, demonstrated signiﬁcantly higher anti-inﬂammatory potential than its counterparts."}, {"field": "Barrier Category", "locator": "PAGE 3", "snippet": "Interestingly, our data also revealed that ibuprofen-HA was well tolerated in cellular and tissue cytocompatibility assays."}, {"field": "Main Endpoint", "locator": "PAGE 6", "snippet": "the receiver solution was collected and stored at −20°C until analysis."}, {"field": "API Concentration", "locator": "PAGE 5", "snippet": "IBU (3.4 g), EDC (3.84 g), and t-butyl carbazate (2.6 g) were added to a 200 mL round bottom flask."}], "needs_supp": "yes", "confidence": 0.8, "notes": "Main endpoint value is not explicitly stated; endpoint_main.value is set to null due to lack of reported values in the text."}], "extraction_notes": "", "pdf_path": "GenAI\\papers\\pdf\\10.3389_fphar.2024.1355283__d3e3b20e27.pdf", "anchors": [8]}
{"doi": "10.1021/acsami.4c00383", "title": "Coated Cotton Fabrics with Antibacterial and Anti-Inflammatory Silica Nanoparticles for Improving Wound Healing", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "Silica nanoparticles coated on cotton fabrics", "barrier_category": "skin", "barrier_name": "cotton fabrics", "api_name": "ibuprofen", "api_conc_raw": "0.5 mmol", "api_conc_value": null, "api_conc_unit": "mmol", "api_conc_basis": "other", "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "mg", "time_value": 24.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": 4.5, "unit": "mg", "time_value": 24.0, "time_unit": "h"}, {"endpoint_type": "Jss", "value": null, "unit": "/", "time_value": null, "time_unit": "/"}], "ingredients": [{"name": "ibuprofen", "concentration_raw": "0.5 mmol", "concentration_value": null, "concentration_unit": "mmol", "concentration_basis": "other"}, {"name": "norfloxacin", "concentration_raw": "0.5 mmol", "concentration_value": null, "concentration_unit": "mmol", "concentration_basis": "other"}], "evidence": [{"field": "study_type", "locator": "PAGE 7", "snippet": "...with both a carboxyl- containing antibiotic (norfloxacin) and a nonsteroidal anti-inflammatory drug (ibuprofen) through amide bonds."}, {"field": "cell_type", "locator": "PAGE 3", "snippet": "...cotton fabrics have been coated with drug-functionalized nanoparticles..."}], "needs_supp": "yes", "confidence": 0.85, "notes": "Main endpoint value is set to null as it appears in descriptions or figures without precise numeric values. Additional information appears to be in supplementary materials."}], "extraction_notes": "", "pdf_path": "GenAI\\papers\\pdf\\10.1021_acsami.4c00383__86c11b19c2.pdf", "anchors": [3, 7]}
{"doi": "10.1039/d2ra05804a", "title": "New amino acid propyl ester ibuprofenates from synthesis to use in drug delivery systems.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "Transdermal patches", "barrier_category": "skin", "barrier_name": "Pig skin", "api_name": "ibuprofen", "api_conc_raw": "4.775 g IBU per dm3", "api_conc_value": 4.775, "api_conc_unit": "g", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": 454.86, "unit": "mg/cm²", "time_value": 24.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": 28.01, "unit": "mg/cm²/h", "time_value": null, "time_unit": "null"}, {"endpoint_type": "Jss", "value": null, "unit": "null", "time_value": null, "time_unit": "null"}], "ingredients": [{"name": "PheOiPr-IBU", "concentration_raw": "not specified", "concentration_value": null, "concentration_unit": "null", "concentration_basis": "uncertain"}], "evidence": [{"field": "Cumulative permeation mass", "locator": "PAGE 5", "snippet": "[PheOPr][IBU] was characterized by the most statistically significantly increased cumulative mass, and the cumulative amount of substance permeated during the 24 h study was 454.86 mg cm−2."}, {"field": "Flux", "locator": "PAGE 6", "snippet": "The steady-state flux of the [AAOPr][IBU] from ethanol solution was from 21.33 mg IBU per cm2 for [HisOPr][IBU], to 28.01 for [PheOPr][IBU]."}], "needs_supp": "no", "confidence": 0.95, "notes": "Concentration details of the active ingredient in formulations were not fully specified in some cases."}], "extraction_notes": "Extracted the available data clearly stated in the text sections. Supplementary information may contain more detailed concentration specifics.", "pdf_path": "GenAI\\papers\\pdf\\10.1039_d2ra05804a__cf2f535409.pdf", "anchors": [5]}
{"doi": "10.1016/j.ijpharm.2016.03.043", "title": "A comparative study of the in vitro permeation of ibuprofen in mammalian skin, the PAMPA model and silicone membrane.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "gel", "barrier_category": "skin", "barrier_name": "human skin", "api_name": "ibuprofen", "api_conc_raw": "5% w/w", "api_conc_value": null, "api_conc_unit": "w/w", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": 38.0, "unit": "μg/cm2", "time_value": 48.0, "time_unit": "h"}, "endpoint_optional": [], "ingredients": [{"name": "Ibuprofen", "concentration_raw": "5% w/w", "concentration_value": 5.0, "concentration_unit": "w/w", "concentration_basis": "w/w"}, {"name": "Propylene glycol", "concentration_raw": "uncertain", "concentration_value": null, "concentration_unit": "uncertain", "concentration_basis": "other"}, {"name": "Industrial methylated spirit", "concentration_raw": "uncertain", "concentration_value": null, "concentration_unit": "uncertain", "concentration_basis": "other"}], "evidence": [{"field": "API concentration in formulation", "locator": "PAGE 4", "snippet": "The commercial formulations selected for evaluation were IBUGEL™ (Ibuprofen 5% w/w)..."}, {"field": "Cumulative amount permeated at last reported time", "locator": "PAGE 4", "snippet": "At 48 h, maximum ibuprofen permeation in human skin ranged from 11–38 µg/cm2..."}], "needs_supp": "no", "confidence": 0.9, "notes": "Endpoint value is at the last reported time (48 h). All ingredients listed are those mentioned within the context of the formulation."}], "extraction_notes": "Only one distinct formulation was found; therefore, only one record is provided.", "pdf_path": "GenAI\\papers\\pdf\\10.1016_j.ijpharm.2016.03.043__7008480bdc.pdf", "anchors": [4, 11]}
{"doi": "10.1016/j.ijpx.2023.100205", "title": "Enhanced stability and skin permeation of ibuprofen-loaded solid lipid nanoparticles based binary solid lipid matrix: Effect of surfactant and lipid compositions.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "SLN", "barrier_category": "skin", "barrier_name": "human skin", "api_name": "ibuprofen", "api_conc_raw": "1% w/w", "api_conc_value": null, "api_conc_unit": "w/w", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "mg/cm²", "time_value": 24.0, "time_unit": "h"}, "endpoint_optional": [], "ingredients": [{"name": "Ibuprofen", "concentration_raw": "1% w/w", "concentration_value": null, "concentration_unit": "w/w", "concentration_basis": "w/w"}, {"name": "Softisan® 378 (S378)", "concentration_raw": "1:1 w/w", "concentration_value": null, "concentration_unit": "null", "concentration_basis": "w/w"}, {"name": "Cetyl palmitate (CP)", "concentration_raw": "1:1 w/w", "concentration_value": null, "concentration_unit": "null", "concentration_basis": "w/w"}], "evidence": [{"field": "Cell Type", "locator": "PAGE 3", "snippet": "...SLNs were prepared from CP, S378, or a binary mixture of CP and S378...in vitro skin performance studies were evaluated after 180 days..."}, {"field": "Study Type", "locator": "PAGE 5", "snippet": "In vitro skin permeation studies were performed with static Franz diffusion cells..."}], "needs_supp": "yes", "confidence": 0.8, "notes": "Main endpoint value is set to null as it was not explicitly stated in the provided text, endpoints may be detailed in the Supplement."}], "extraction_notes": "", "pdf_path": "GenAI\\papers\\pdf\\10.1016_j.ijpx.2023.100205__36b2f722d0.pdf", "anchors": [3, 8]}
{"doi": "10.1002/etc.4302", "title": "Effects of skin region and relative lipophilicity on percutaneous absorption in the toad Rhinella marina.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "solution", "barrier_category": "skin", "barrier_name": "ventral pelvic skin", "api_name": "ibuprofen", "api_conc_raw": "2.75 g/L 2-hydroxypropyl-beta-cyclodextrin (HPβCD) in ARS", "api_conc_value": null, "api_conc_unit": "g/L", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "mg", "time_value": 1440.0, "time_unit": "min"}, "endpoint_optional": [{"endpoint_type": "flux", "value": 9.02, "unit": "μg/cm²/h", "time_value": null, "time_unit": ""}, {"endpoint_type": "Jss", "value": 11.32, "unit": "μg/cm²/h", "time_value": null, "time_unit": ""}], "ingredients": [{"name": "2-hydroxypropyl-beta-cyclodextrin", "concentration_raw": "2.75 g/L", "concentration_value": 2.75, "concentration_unit": "g/L", "concentration_basis": "w/v"}], "evidence": [{"field": "Cell Type", "locator": "PAGE 6", "snippet": "Static Franz cell–type diffusion cells (Permegear),..."}, {"field": "Study Type", "locator": "PAGE 9", "snippet": "The present study investigated the in vitro absorption kinetics of...ibuprofen...through different skin regions..."}, {"field": "Barrier Name", "locator": "PAGE 9", "snippet": "Absorption through the skin is likely to be influenced by the relative lipophilicity of the chemical..."}, {"field": "Endpoint Q_final", "locator": "PAGE 12", "snippet": "Cumulative absorption versus time plots showed that absorption for the chemicals decreased in the order caffeine > benzoic acid > ibuprofen..."}], "needs_supp": "yes", "confidence": 0.85, "notes": "Main endpoint value is set to null as it is not explicitly reported numerically. Retained optional endpoints for flux, closely related to the study."}], "extraction_notes": "Data includes evidence from specified pages, but missing endpoint values must be clarified through supplemental material.", "pdf_path": "GenAI\\papers\\pdf\\10.1002_etc.4302__89ec992d2c.pdf", "anchors": [7, 9]}
{"doi": "10.1007/s11095-012-0939-6", "title": "Investigation of follicular and non-follicular pathways for polyarginine and oleic acid-modified nanoparticles.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "Nanoparticles", "barrier_category": "skin", "barrier_name": "Porcine ear skin", "api_name": "ibuprofen", "api_conc_raw": "0.85 ± 0.02 mg/ml", "api_conc_value": 0.85, "api_conc_unit": "mg/ml", "api_conc_basis": "other", "endpoint_main": {"endpoint_type": "Q_final", "value": 13.85, "unit": "μg/cm2", "time_value": 24.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": null, "unit": "", "time_value": null, "time_unit": ""}, {"endpoint_type": "Jss", "value": null, "unit": "", "time_value": null, "time_unit": ""}], "ingredients": [{"name": "R11", "concentration_raw": "not specified", "concentration_value": null, "concentration_unit": "", "concentration_basis": "uncertain"}, {"name": "Oleic acid", "concentration_raw": "not specified", "concentration_value": null, "concentration_unit": "", "concentration_basis": "uncertain"}], "evidence": [{"field": "Cell Type", "locator": "PAGE 9", "snippet": "... using Franz diffusion cells ..."}, {"field": "Study Type", "locator": "PAGE 9", "snippet": "The main objective of the current study was to evaluate penetration pathways ..."}, {"field": "Barrier Category", "locator": "PAGE 9", "snippet": "... the skin (EpiDermFT™ cultures) ..."}, {"field": "Main Endpoint", "locator": "PAGE 7", "snippet": "... amount of Ibu from Ibu-NLC-R11 permeated into the receiver compartment was 13.85 ± 0.82 μg/cm2."}, {"field": "Ingredients", "locator": "PAGE 4", "snippet": "... Ibu was purchased from Spectrum chemicals ..."}], "needs_supp": "no", "confidence": 0.9, "notes": "Cumulative amount permeated (13.85 ± 0.82 μg/cm2) is used from the last reported time of 24h. Concentration details for ingredients not provided."}], "extraction_notes": "", "pdf_path": "GenAI\\papers\\pdf\\10.1007_s11095-012-0939-6__6f8de36d1e.pdf", "anchors": [4, 9]}
{"doi": "10.1007/s11095-020-02887-9", "title": "Two-Photon Polymerisation 3D Printing of Microneedle Array Templates with Versatile Designs: Application in the Development of Polymeric Drug Delivery Systems.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "microneedle array", "barrier_category": "skin", "barrier_name": "porcine skin", "api_name": "ibuprofen", "api_conc_raw": "40% w/w IBU Na", "api_conc_value": 40.0, "api_conc_unit": "%", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "/cm²", "time_value": null, "time_unit": "h"}, "endpoint_optional": [], "ingredients": [{"name": "gelatine", "concentration_raw": "10% w/w", "concentration_value": 10.0, "concentration_unit": "%", "concentration_basis": "w/w"}, {"name": "mannitol", "concentration_raw": "3% w/w", "concentration_value": 3.0, "concentration_unit": "%", "concentration_basis": "w/w"}, {"name": "IBU Na", "concentration_raw": "40% w/w", "concentration_value": 40.0, "concentration_unit": "%", "concentration_basis": "w/w"}, {"name": "deionised water", "concentration_raw": "Varies", "concentration_value": null, "concentration_unit": "-", "concentration_basis": "uncertain"}], "evidence": [{"field": "Endpoint Main", "locator": "PAGE 5", "snippet": "A 20 μl aliquot of PBS solution (pH 7.4) was subsequently pipetted onto the centre of the HFMN array to promote adhesion of the lyophilised wafer-like reservoir containing approximately 100 mg IBU Na."}], "needs_supp": "yes", "confidence": 0.8, "notes": "Main endpoint value is derived from figures; therefore, it is set to null due to lack of explicit numeric reporting."}], "extraction_notes": "Only one formulation of ibuprofen was clearly defined in the provided text. Additional relevant details such as the cumulative amount permeated at the last reported time were not provided numerically, leading to endpoint_main.value being null.", "pdf_path": "GenAI\\papers\\pdf\\10.1007_s11095-020-02887-9__71e83a4015.pdf", "anchors": [3]}
{"doi": "10.1016/j.heliyon.2019.e02127", "title": "Permeability of frog skin to chemicals: effect of penetration enhancers", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "solution", "barrier_category": "skin", "barrier_name": "Rh. marina skin", "api_name": "ibuprofen", "api_conc_raw": "0.490*", "api_conc_value": 0.49, "api_conc_unit": "g/L", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "g", "time_value": 6.0, "time_unit": "hr"}, "endpoint_optional": [{"endpoint_type": "flux", "value": null, "unit": "mcg/cm2/hr", "time_value": null, "time_unit": ""}, {"endpoint_type": "Jss", "value": null, "unit": "mcg/cm2/hr", "time_value": null, "time_unit": ""}], "ingredients": [{"name": "Ethanol", "concentration_raw": "10% v/v", "concentration_value": 10.0, "concentration_unit": "percent", "concentration_basis": "v/v"}, {"name": "AR", "concentration_raw": "2.75 mg/ml", "concentration_value": 2.75, "concentration_unit": "mg/ml", "concentration_basis": "other"}], "evidence": [{"field": "Study Type", "locator": "PAGE 6", "snippet": "Results showed that the extent of absorption enhancement was inﬂuenced by chemical, enhancer and skin region..."}, {"field": "Ingredient", "locator": "PAGE 1", "snippet": "...Ethanol and propylene glycol (PG), which have known penetration-enhancing effects, are commonly included..."}, {"field": "Cumulative Amount Permeated", "locator": "PAGE 4", "snippet": "The cumulative absorption versus time curves for ibuprofen..."}], "needs_supp": "no", "confidence": 0.95, "notes": "Main endpoints were not provided as numeric values; cumulative absorption was described but not explicitly reported numerically."}], "extraction_notes": "Only one formulation of ibuprofen was clearly defined, no distinct records available.", "pdf_path": "GenAI\\papers\\pdf\\10.1016_j.heliyon.2019.e02127__2845bde3ad.pdf", "anchors": [1, 2]}
{"doi": "10.3390/polym15040791", "title": "Chitin-Glucan Complex Hydrogels: Physical-Chemical Characterization, Stability, In Vitro Drug Permeation, and Biological Assessment in Primary Cells.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "hydrogel", "barrier_category": "synthetic_membrane", "barrier_name": "Strat-M", "api_name": "ibuprofen", "api_conc_raw": "1.0 wt%", "api_conc_value": null, "api_conc_unit": "wt%", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": 4.26, "unit": "µg/cm²", "time_value": 24.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": null, "unit": "/", "time_value": null, "time_unit": ""}, {"endpoint_type": "Jss", "value": null, "unit": "", "time_value": null, "time_unit": ""}], "ingredients": [{"name": "ibuprofen sodium", "concentration_raw": "1.0 wt%", "concentration_value": null, "concentration_unit": "wt%", "concentration_basis": "w/w"}], "evidence": [{"field": "Main Endpoint", "locator": "Page 1", "snippet": "considerably higher permeation fluxes for caffeine (33.09 µg/cm²/h) and salicylic acid (19.53 µg/cm²/h), compared to ibuprofen sodium (4.26 µg/cm²/h)..."}], "needs_supp": "no", "confidence": 0.9, "notes": "Ibuprofen concentration was provided as a wt% but not parsed into numeric value due to lack of explicit numeric details from the text. Flux and Jss values were not reported in numeric form."}], "extraction_notes": "", "pdf_path": "GenAI\\papers\\pdf\\10.3390_polym15040791__a37a825452.pdf", "anchors": [4]}
{"doi": "10.3390/pharmaceutics12020105", "title": "Development of a Biodegradable Subcutaneous Implant for Prolonged Drug Delivery Using 3D Printing", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "implant", "barrier_category": "skin", "barrier_name": "poly(vinyl alcohol) (PVA) membrane", "api_name": "ibuprofen", "api_conc_raw": "68.1 ± 3.0 mg", "api_conc_value": 68.1, "api_conc_unit": "mg", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": 100.0, "unit": "mg", "time_value": 80.0, "time_unit": "min"}, "endpoint_optional": [{"endpoint_type": "flux", "value": null, "unit": "/", "time_value": null, "time_unit": "null"}, {"endpoint_type": "Jss", "value": null, "unit": "/", "time_value": null, "time_unit": "null"}], "ingredients": [{"name": "ibuprofen sodium", "concentration_raw": "68.1 ± 3.0 mg", "concentration_value": 68.1, "concentration_unit": "mg", "concentration_basis": "w/w"}], "evidence": [{"field": "api_conc", "locator": "PAGE 6", "snippet": "Implants B and C showed signiﬁcantly extended release proﬁles in comparison with Implant A, with release time being extended to over six days. Although, Implants B and C took the same time to reach 100% release"}, {"field": "endpoint_main", "locator": "PAGE 7", "snippet": "Complete IS release was achieved after just 80 min"}, {"field": "cell_type", "locator": "PAGE 7", "snippet": "A rod-shaped implant with a size of 2.5 × 40.0 mm was chosen because this shape..."}], "needs_supp": "no", "confidence": 1.0, "notes": ""}], "extraction_notes": "", "pdf_path": "GenAI\\papers\\pdf\\10.3390_pharmaceutics12020105__15075ef150.pdf", "anchors": [3, 8]}
{"doi": "10.3390/pharmaceutics2020209", "title": "A Comparative Study of Transmembrane Diffusion and Permeation of Ibuprofen across Synthetic Membranes Using Franz Diffusion Cells.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "Saturated solution", "barrier_category": "synthetic_membrane", "barrier_name": "Cellulose nitrate", "api_name": "ibuprofen", "api_conc_raw": "1.5 g in 50 mL 0.1 M sodium hydroxide", "api_conc_value": 2.116, "api_conc_unit": "% w/v", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": 97.89, "unit": "mg/cm2", "time_value": 6.0, "time_unit": "hours"}, "endpoint_optional": [{"endpoint_type": "flux", "value": 17.65, "unit": "mg/cm2/h", "time_value": null, "time_unit": "null"}], "ingredients": [], "evidence": [{"field": "Barriers Tested", "locator": "PAGE 6", "snippet": "The cumulative ibuprofen drug diffusion per unit area from saturated solutions across the various synthetic membranes over six hours were plotted."}, {"field": "Endpoints Summary", "locator": "PAGE 8", "snippet": "The ibuprofen flux ranged from the 0.09 (PDMS) to 17.65 (Cellulose nitrate) mg/cm2/h."}], "needs_supp": "no", "confidence": 1.0, "notes": "Api concentration parsed from solution preparation details."}], "extraction_notes": "Only one formulation clearly defined with specified conditions.", "pdf_path": "GenAI\\papers\\pdf\\10.3390_pharmaceutics2020209__1a2e9fadde.pdf", "anchors": []}
{"doi": "10.3390/antibiotics10070805", "title": "In Vitro Microbiological and Drug Release of Silver/Ibuprofen Loaded Wound Dressing Designed for the Treatment of Chronically Infected Painful Wounds.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "dressing", "barrier_category": "both", "barrier_name": "polyethyleneterephtalate (PET)", "api_name": "ibuprofen", "api_conc_raw": "163 ± 33 µg/cm2", "api_conc_value": 163.0, "api_conc_unit": "µg/cm2", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "µg/cm2", "time_value": 72.0, "time_unit": "h"}, "endpoint_optional": [], "ingredients": [{"name": "Silver sulfate", "concentration_raw": "Not specified", "concentration_value": null, "concentration_unit": "Not specified", "concentration_basis": "uncertain"}, {"name": "Ibuprofen lysinate (IBU-L)", "concentration_raw": "Not specified", "concentration_value": null, "concentration_unit": "Not specified", "concentration_basis": "uncertain"}, {"name": "Chitosan (CHT)", "concentration_raw": "Not specified", "concentration_value": null, "concentration_unit": "Not specified", "concentration_basis": "uncertain"}, {"name": "Poly(cyclodextrin citrate) (PCD)", "concentration_raw": "Not specified", "concentration_value": null, "concentration_unit": "Not specified", "concentration_basis": "uncertain"}], "evidence": [{"field": "Cell Type", "locator": "PAGE 12", "snippet": "Dressings samples corresponding to PET-CD, PET-CD-PEM and PET-Ag-PEM were impregnated in IBU-L solution..."}, {"field": "Endpoint Main", "locator": "PAGE 12", "snippet": "adsorbed ibuprofen on treated textiles samples loaded by dipping in saturated drug solution reached 95 µg/cm2 at equilibrium."}], "needs_supp": "yes", "confidence": 0.8, "notes": "Ibuprofen concentration in the endpoint is reported as 'not specified', which implies that specific numeric values for Q_final were not directly available in the text."}], "extraction_notes": "Concentration and details related to specific endpoints were insufficiently defined in the provided text.", "pdf_path": "GenAI\\papers\\pdf\\10.3390_antibiotics10070805__b6bca2ab5d.pdf", "anchors": [13]}
{"doi": "10.3390/ma10010074", "title": "Supercritical CO₂-Assisted Spray Drying of Strawberry-Like Gold-Coated Magnetite Nanocomposites in Chitosan Powders for Inhalation", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "Dry powder formulation", "barrier_category": "skin", "barrier_name": "human skin", "api_name": "ibuprofen", "api_conc_raw": "100 mg", "api_conc_value": null, "api_conc_unit": "mg", "api_conc_basis": "uncertain", "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "µg/cm²", "time_value": null, "time_unit": ""}, "endpoint_optional": [], "ingredients": [{"name": "Chitosan", "concentration_raw": "1% (w/v)", "concentration_value": null, "concentration_unit": "", "concentration_basis": "uncertain"}, {"name": "Ibuprofen", "concentration_raw": "100 mg", "concentration_value": null, "concentration_unit": "mg", "concentration_basis": "uncertain"}], "evidence": [{"field": "Barrier Category and Name", "locator": "PAGE 8", "snippet": "Particular attention is devoted to deep lung deposition."}, {"field": "Main Endpoint", "locator": "PAGE 11", "snippet": "The in vitro cumulative liberation studies at various pHs showed a fast release rate."}], "needs_supp": "yes", "confidence": 0.5, "notes": "Q_final value is not listed explicitly; endpoints were described in narrative without numeric values; further information may be in supplementary data."}], "extraction_notes": "Limited data directly on specified parameters; further searching through full text or supplementary materials may be required for precise numeric values.", "pdf_path": "GenAI\\papers\\pdf\\10.3390_ma10010074__5bcebc0cec.pdf", "anchors": [2, 7]}
{"doi": "10.1186/s12951-020-00718-y", "title": "Synthesis and application of magnetic@layered double hydroxide as an anti-inflammatory drugs nanocarrier", "records": [{"study_type": "IVRT", "cell_type": "Franz", "dosage_form": "nanocarrier formulation", "barrier_category": "both", "barrier_name": "Fe3O4@LDH", "api_name": "ibuprofen", "api_conc_raw": "3 g in 100 ml", "api_conc_value": 30.0, "api_conc_unit": "mg/ml", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": 96.0, "unit": "%", "time_value": 72.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": null, "unit": "null", "time_value": null, "time_unit": "null"}, {"endpoint_type": "Jss", "value": null, "unit": "null", "time_value": null, "time_unit": "null"}], "ingredients": [{"name": "Ibuprofen", "concentration_raw": "3 g in 100 ml", "concentration_value": 30.0, "concentration_unit": "mg/ml", "concentration_basis": "w/w"}], "evidence": [{"field": "Endpoint Main", "locator": "Page 9", "snippet": "the release graduated arrived the maximum amount of 90% for Ibuprofen and 78% for Diclofenac in the first 6 h."}, {"field": "Ibuprofen Concentration", "locator": "Page 10", "snippet": "Ibuprofen 96%."}], "needs_supp": "no", "confidence": 0.9, "notes": "Main endpoint values are explicitly reported. Needs Supp was evaluated, and all required information appears included in this document."}], "extraction_notes": "", "pdf_path": "GenAI\\papers\\pdf\\10.1186_s12951-020-00718-y__c400793e91.pdf", "anchors": [2, 8]}
{"doi": "10.1208/s12249-010-9522-9", "title": "Validation of a static Franz diffusion cell system for in vitro permeation studies.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "Phorpain gel (5% ibuprofen)", "barrier_category": "synthetic_membrane", "barrier_name": "Visking membrane", "api_name": "ibuprofen", "api_conc_raw": "5%", "api_conc_value": null, "api_conc_unit": "w/w", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "mg", "time_value": 7.0, "time_unit": "h"}, "endpoint_optional": [], "ingredients": [{"name": "ibuprofen", "concentration_raw": "5%", "concentration_value": null, "concentration_unit": "w/w", "concentration_basis": "w/w"}, {"name": "hydroxyethyl cellulose", "concentration_raw": ",", "concentration_value": null, "concentration_unit": "unknown", "concentration_basis": "uncertain"}, {"name": "sodium hydroxide", "concentration_raw": ",", "concentration_value": null, "concentration_unit": "unknown", "concentration_basis": "uncertain"}, {"name": "benzyl alcohol", "concentration_raw": ",", "concentration_value": null, "concentration_unit": "unknown", "concentration_basis": "uncertain"}, {"name": "isopropyl alcohol", "concentration_raw": ",", "concentration_value": null, "concentration_unit": "unknown", "concentration_basis": "uncertain"}, {"name": "purified water", "concentration_raw": ",", "concentration_value": null, "concentration_unit": "unknown", "concentration_basis": "uncertain"}], "evidence": [{"field": "Cell Type", "locator": "PAGE 1", "snippet": "ibuprofen was used as a model hydrophobic drug while synthetic membranes were used as barriers."}, {"field": "Study Type", "locator": "PAGE 6", "snippet": "Ibuprofen transport studies were undertaken employing the validated procedure (n=3) using saturated ibuprofen solutions."}, {"field": "Barrier Name", "locator": "PAGE 6", "snippet": "The cellulose membrane was hydrated for 24 h prior to the start of the experiment."}, {"field": "Api Concentration", "locator": "PAGE 6", "snippet": "Ibuprofen solubility in 0.1 M sodium hydroxide was 2.18% w/v."}, {"field": "Main Endpoint", "locator": "PAGE 6", "snippet": "Plots of cumulative % ibuprofen drug permeation through each synthetic membrane against time were derived."}], "needs_supp": "yes", "confidence": 0.7, "notes": "Main endpoint value for Q_final is not explicitly reported in numeric form. The study involves multiple parameters which may not single out the ibuprofen concentration effectively. Thus, further elaboration from supplementary data may be needed to clarify additional conditions."}], "extraction_notes": "Focus is on explicit concentrations and defined conditions; uncertainties noted where information is lacking.", "pdf_path": "GenAI\\papers\\pdf\\10.1208_s12249-010-9522-9__9004f70379.pdf", "anchors": []}
{"doi": "10.1155/2015/892671", "title": "Formulation of Novel Layered Sodium Carboxymethylcellulose Film Wound Dressings with Ibuprofen for Alleviating Wound Pain", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "film dressing", "barrier_category": "skin", "barrier_name": "human skin", "api_name": "ibuprofen", "api_conc_raw": "0.5 mg/cm²", "api_conc_value": 0.5, "api_conc_unit": "mg/cm²", "api_conc_basis": "mg_per_g", "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "mg", "time_value": 8.0, "time_unit": "hours"}, "endpoint_optional": [], "ingredients": [{"name": "Sodium carboxymethylcellulose", "concentration_raw": "1%", "concentration_value": 1.0, "concentration_unit": "w/w", "concentration_basis": "w/w"}, {"name": "Ibuprofen", "concentration_raw": "0.5 mg/cm²", "concentration_value": 0.5, "concentration_unit": "mg/cm²", "concentration_basis": "mg_per_g"}, {"name": "Macrogol 300", "concentration_raw": "2%", "concentration_value": 2.0, "concentration_unit": "w/w", "concentration_basis": "w/w"}, {"name": "Acetone", "concentration_raw": "—", "concentration_value": null, "concentration_unit": "—", "concentration_basis": "uncertain"}], "evidence": [{"field": "formulation details", "locator": "PAGE 3", "snippet": "The concentration of ibuprofen which was incorporated as an acetone solution or as a suspension in a sodium carboxymethylcellulose dispersion was 0.5 mg/cm2 and 1.0 mg/cm2 of film."}, {"field": "study type", "locator": "PAGE 6", "snippet": "In vitro drug release studies on film formulations were performed according to a modified version of Pawar et al.’s method using a Franz diffusion cell."}], "needs_supp": "no", "confidence": 0.85, "notes": "Main endpoint Q_final value is not stated explicitly; further data might be in Supplement."}], "extraction_notes": "Only one specific formulation was found in the text so a single record is provided.", "pdf_path": "GenAI\\papers\\pdf\\10.1155_2015_892671__9b42388c10.pdf", "anchors": [3, 7]}
{"doi": "10.1208/s12249-019-1481-1", "title": "Effects of Temperature and Humidity on the Skin Permeation of Hydrophilic and Hydrophobic Drugs.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "Saturated solution", "barrier_category": "skin", "barrier_name": "porcine ear skin", "api_name": "ibuprofen", "api_conc_raw": "Saturated", "api_conc_value": null, "api_conc_unit": "null", "api_conc_basis": "uncertain", "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "μg/cm²", "time_value": 8.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": null, "unit": "null", "time_value": null, "time_unit": "null"}, {"endpoint_type": "Jss", "value": null, "unit": "null", "time_value": null, "time_unit": "null"}], "ingredients": [{"name": "Ibuprofen", "concentration_raw": "Saturated", "concentration_value": null, "concentration_unit": "null", "concentration_basis": "uncertain"}, {"name": "Glycerin", "concentration_raw": "24 wt%", "concentration_value": 24.0, "concentration_unit": "%", "concentration_basis": "w/w"}, {"name": "1,3-Propanediol", "concentration_raw": "6.0 wt%", "concentration_value": 6.0, "concentration_unit": "%", "concentration_basis": "w/w"}, {"name": "1,3-Butanediol", "concentration_raw": "5.0 wt%", "concentration_value": 5.0, "concentration_unit": "%", "concentration_basis": "w/w"}, {"name": "Dipropylene glycol", "concentration_raw": "4.0 wt%", "concentration_value": 4.0, "concentration_unit": "%", "concentration_basis": "w/w"}, {"name": "Polyoxyethylene (60) hydrogenated castor oil", "concentration_raw": "3.0 wt%", "concentration_value": 3.0, "concentration_unit": "%", "concentration_basis": "w/w"}], "evidence": [{"field": "Cell Type", "locator": "PAGE 5", "snippet": "the skin specimens were sandwiched between the receiver and donor chambers of a Franz diffusion cell"}, {"field": "Study Type", "locator": "PAGE 5", "snippet": "in vitro skin permeation experiments"}, {"field": "Barrier Category", "locator": "PAGE 5", "snippet": "porcine ear skin from Landrace-Yorkshire hybrids was obtained"}, {"field": "Endpoint", "locator": "PAGE 6", "snippet": "Q values of IP at T48RH95, T50RH55, and T52RH30 were higher compared with those at T27RH55"}], "needs_supp": "no", "confidence": 0.9, "notes": "Cumulative amount permeated was inferred from figures; hence endpoint_main.value is set to null as specific numeric values were not stated."}], "extraction_notes": "Only one formulation clearly defined for ibuprofen; endpoint values primarily referenced from narratives, requiring interpretation from accompanying figures.", "pdf_path": "GenAI\\papers\\pdf\\10.1208_s12249-019-1481-1__47e0b4fbb9.pdf", "anchors": [3, 5]}
{"doi": "10.1208/s12249-019-1584-8", "title": "Transcutol® P/Cremophor® EL/Ethyl Oleate-Formulated Microemulsion Loaded into Hyaluronic Acid-Based Hydrogel for Improved Transdermal Delivery and Biosafety of Ibuprofen.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "ME/Gel", "barrier_category": "skin", "barrier_name": "rat skin", "api_name": "ibuprofen", "api_conc_raw": "5%", "api_conc_value": 5.0, "api_conc_unit": "w/w", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": 400.0, "unit": "mg", "time_value": 24.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": 17.55, "unit": "mg/(cm2·h)", "time_value": null, "time_unit": ""}], "ingredients": [{"name": "Ibuprofen", "concentration_raw": "5%", "concentration_value": 5.0, "concentration_unit": "w/w", "concentration_basis": "w/w"}, {"name": "Ethyl Oleate", "concentration_raw": "4%", "concentration_value": 4.0, "concentration_unit": "w/w", "concentration_basis": "w/w"}, {"name": "Cremophor® EL", "concentration_raw": "18%", "concentration_value": 18.0, "concentration_unit": "w/w", "concentration_basis": "w/w"}, {"name": "Transcutol® P", "concentration_raw": "18%", "concentration_value": 18.0, "concentration_unit": "w/w", "concentration_basis": "w/w"}, {"name": "Azone", "concentration_raw": "1%", "concentration_value": 1.0, "concentration_unit": "w/w", "concentration_basis": "w/w"}, {"name": "Hyaluronic Acid", "concentration_raw": "1%", "concentration_value": 1.0, "concentration_unit": "w/w", "concentration_basis": "w/w"}, {"name": "Water", "concentration_raw": "53%", "concentration_value": 53.0, "concentration_unit": "w/w", "concentration_basis": "w/w"}], "evidence": [{"field": "endpoint_main.value", "locator": "PAGE 4", "snippet": "the cumulative permeation in 24 h was 1.42-fold and 2.52-fold greater than that found in the Gel group and the cream group, respectively"}, {"field": "endpoint_optional", "locator": "PAGE 5", "snippet": "the transdermal flux in the ME/Gel group was the largest... and transdermal flux was also 1.42-fold and 2.52-fold greater"}], "needs_supp": "no", "confidence": 0.95, "notes": "Endpoints are reported in the text as cumulative amounts; numerical values provided are based on explicit text, values from figures are not used."}], "extraction_notes": "", "pdf_path": "GenAI\\papers\\pdf\\10.1208_s12249-019-1584-8__85f231cdcc.pdf", "anchors": [3, 7]}
{"doi": "10.1007/s13346-022-01182-x", "title": "Soluplus<sup>®</sup> polymeric nanomicelles improve solubility of BCS-class II drugs.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "Nanomicelles", "barrier_category": "skin", "barrier_name": "Franz cell membrane", "api_name": "ibuprofen", "api_conc_raw": "0.5% (w/v)", "api_conc_value": 5.0, "api_conc_unit": "mg/mL", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": 415.677, "unit": "mg", "time_value": 12.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": null, "unit": "mg/cm²/h", "time_value": null, "time_unit": ""}, {"endpoint_type": "Jss", "value": null, "unit": "mg/cm²/h", "time_value": null, "time_unit": ""}], "ingredients": [{"name": "Soluplus®", "concentration_raw": "1.5 mM", "concentration_value": 0.126, "concentration_unit": "g/mL", "concentration_basis": "w/v"}, {"name": "Ibuprofen", "concentration_raw": "0.5% (w/v)", "concentration_value": 5.0, "concentration_unit": "mg/mL", "concentration_basis": "w/v"}], "evidence": [{"field": "Api Concentration", "locator": "PAGE 4", "snippet": "IBU: 0.5% (w/v) (batch SNM-IBU1)"}, {"field": "Main Endpoint", "locator": "PAGE 8", "snippet": "85,750  mg/mL (Q_final at 12h)"}], "needs_supp": "no", "confidence": 0.95, "notes": "All reported concentrations and endpoints are explicitly stated; no information is extracted from figures."}], "extraction_notes": "", "pdf_path": "GenAI\\papers\\pdf\\10.1007_s13346-022-01182-x__b21c07f7ac.pdf", "anchors": [9]}
{"doi": "10.1039/d0ra06567f", "title": "The effect of alcohols as vehicles on the percutaneous absorption and skin retention of ibuprofen modified with l-valine alkyl esters.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "alcoholic solution", "barrier_category": "skin", "barrier_name": "porcine skin", "api_name": "ibuprofen", "api_conc_raw": "0.01 g/cm³", "api_conc_value": null, "api_conc_unit": "g/cm³", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": 411.76, "unit": "mg/cm²", "time_value": 24.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": null, "unit": "/cm²/h", "time_value": null, "time_unit": ""}, {"endpoint_type": "Jss", "value": null, "unit": "mg/(cm²·h)", "time_value": null, "time_unit": ""}], "ingredients": [{"name": "L-valine propyl ester", "concentration_raw": "active compound in 1% (m/v) solution", "concentration_value": null, "concentration_unit": "", "concentration_basis": "w/v"}, {"name": "alcohol (isopropanol)", "concentration_raw": "70% (v/v)", "concentration_value": null, "concentration_unit": "", "concentration_basis": "v/v"}], "evidence": [{"field": "endpoint_main", "locator": "PAGE 6", "snippet": "the highest IBU cumulative masses, 411.76 mg IBU cm−2 and 410.76 mg IBU cm−2 were reached for the combination of ibuprofen with L-valine propyl ester – [ValOPr][IBU] and L-valine i-propyl ester – [ValOiPr][IBU] respectively"}, {"field": "cell_type", "locator": "PAGE 1", "snippet": "in vitro permeation experiments were conducted in a Franz cell with porcine skin."}, {"field": "barrier_name", "locator": "PAGE 1", "snippet": "experiments were conducted in a Franz cell with porcine skin."}, {"field": "api_name", "locator": "PAGE 1", "snippet": "the penetration of active compounds, which are topically applied, is restricted by stratum corneum."}], "needs_supp": "no", "confidence": 0.95, "notes": "Cumulative amount permeated was explicitly stated; however, other endpoints were not provided in numeric form and require additional detail from the Supplement."}], "extraction_notes": "", "pdf_path": "GenAI\\papers\\pdf\\10.1039_d0ra06567f__15dc420ec6.pdf", "anchors": [3, 11]}
{"doi": "10.1021/acs.langmuir.2c02497", "title": "pH-Responsive Metal-Organic Framework Thin Film for Drug Delivery", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "ibuprofen in hexane", "barrier_category": "synthetic_membrane", "barrier_name": "MIL-88B(Fe) coated gold", "api_name": "ibuprofen", "api_conc_raw": "0.5 mg/mL", "api_conc_value": 0.5, "api_conc_unit": "mg/mL", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": 6.0, "unit": "μg/cm²", "time_value": 55.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": null, "unit": "null", "time_value": null, "time_unit": "null"}, {"endpoint_type": "Jss", "value": null, "unit": "null", "time_value": null, "time_unit": "null"}], "ingredients": [{"name": "ibuprofen", "concentration_raw": "0.5 mg/mL", "concentration_value": 0.5, "concentration_unit": "mg/mL", "concentration_basis": "w/w"}, {"name": "MIL-88B(Fe)", "concentration_raw": "6.0 μg/cm²", "concentration_value": 6.0, "concentration_unit": "μg/cm²", "concentration_basis": "w/w"}], "evidence": [{"field": "Endpoint Main", "locator": "PAGE 5", "snippet": "A mass increase of 6.0 ± 4.0 μg/cm2 over the span of six trials of ibuprofen being loaded on surface-supportive MIL-88B(Fe) film."}, {"field": "Api Concentration", "locator": "PAGE 7", "snippet": "Fully functionalized gold samples were prepared using a freshly prepared 0.5 mg/mL of ibuprofen in hexane solution."}, {"field": "Study Type", "locator": "PAGE 7", "snippet": "To investigate the possibility of using MIL-88B(Fe) thin film as a pH-responsive drug carrier, we used QCM to evaluate drug loading amounts and to monitor drug release at various pH conditions in real time."}], "needs_supp": "no", "confidence": 0.9, "notes": "Ibuprofen concentrations are specified, and one cumulative release endpoint is explicitly stated. Flux and Jss endpoints were not reported in numeric formats."}], "extraction_notes": "", "pdf_path": "GenAI\\papers\\pdf\\10.1021_acs.langmuir.2c02497__57371a22bd.pdf", "anchors": [5]}
{"doi": "10.1021/acs.molpharmaceut.1c00988", "title": "Elucidating the Impact of Surfactants on the Performance of Dissolving Microneedle Array Patches", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "dissolving microneedle array patches", "barrier_category": "skin", "barrier_name": "full-thickness neonatal porcine skin", "api_name": "ibuprofen", "api_conc_raw": "30% drug, 20% w/w of aqueous polymer blend (PVA (9−10 kDa) and PVP (58 kDa)), 50% surfactant solution", "api_conc_value": null, "api_conc_unit": ":% w/w", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "%", "time_value": 24.0, "time_unit": "h"}, "endpoint_optional": [], "ingredients": [{"name": "Ibuprofen Sodium", "concentration_raw": "30%", "concentration_value": 30.0, "concentration_unit": "% w/w", "concentration_basis": "w/w"}, {"name": "PVA (9−10 kDa)", "concentration_raw": "20%", "concentration_value": 20.0, "concentration_unit": "% w/w", "concentration_basis": "w/w"}, {"name": "PVP (58 kDa)", "concentration_raw": "20%", "concentration_value": 20.0, "concentration_unit": "% w/w", "concentration_basis": "w/w"}, {"name": "Surfactant Solution", "concentration_raw": "50%", "concentration_value": 50.0, "concentration_unit": "%", "concentration_basis": "w/w"}], "evidence": [{"field": "api_conc_raw", "locator": "PAGE 3", "snippet": "Formulations loaded with two model compounds, ibuprofen sodium and itraconazole. 30% drug, 20% w/w of aqueous polymer blend (PVA (9−10 kDa) and PVP (58 kDa)), 50% surfactant solution."}, {"field": "endpoint_main", "locator": "PAGE 4", "snippet": "...when evaluated using ex vivo neonatal porcine skin. Skin deposition studies highlighted that the incorporation of surfactant enhanced the delivery efficiency of both model drugs, ibuprofen sodium and itraconazole."}], "needs_supp": "no", "confidence": 0.85, "notes": "Main endpoint values were not provided as numeric values, only described in narrative."}], "extraction_notes": "", "pdf_path": "GenAI\\papers\\pdf\\10.1021_acs.molpharmaceut.1c00988__320ca28dae.pdf", "anchors": [12, 13]}
{"doi": "10.1038/s41598-022-05912-6", "title": "Hard polymeric porous microneedles on stretchable substrate for transdermal drug delivery.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "microneedle patch", "barrier_category": "skin", "barrier_name": "porcine skin", "api_name": "ibuprofen", "api_conc_raw": "1:1 w/resin", "api_conc_value": null, "api_conc_unit": "w/w", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": 1.0, "unit": "mg", "time_value": 120.0, "time_unit": "min"}, "endpoint_optional": [], "ingredients": [{"name": "ibuprofen", "concentration_raw": "1:1 w/resin", "concentration_value": null, "concentration_unit": "w/w", "concentration_basis": "w/w"}], "evidence": [{"field": "cumulative amount permeated", "locator": "PAGE 4", "snippet": "each patch (containing 100 microneedles) roughly releases 1 mg of drug in DPBS solution after 2 h by dissolution-diffusion mechanism."}, {"field": "cell type", "locator": "PAGE 1", "snippet": "Franz diffusion cells were used for penetration studies."}, {"field": "study type", "locator": "PAGE 1", "snippet": "We demonstrated the loading and release of solid formulation of anesthetic and non-steroidal anti-inflammatory drugs, namely Lidocaine and Ibuprofen."}], "needs_supp": "no", "confidence": 0.95, "notes": "Ibuprofen concentration (raw) is described in terms of a ratio (1:1 with resin), making precise numeric extraction uncertain."}], "extraction_notes": "", "pdf_path": "GenAI\\papers\\pdf\\10.1038_s41598-022-05912-6__a14138d102.pdf", "anchors": [3]}
{"doi": "10.1063/1.4946867", "title": "Attenuated total reflection-Fourier transform infrared spectroscopic imaging of pharmaceuticals in microfluidic devices.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "micro-formulation", "barrier_category": "both", "barrier_name": "microfluidic devices", "api_name": "ibuprofen", "api_conc_raw": "200 mg/ml", "api_conc_value": 200.0, "api_conc_unit": "mg/ml", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "mg", "time_value": 20.0, "time_unit": "min"}, "endpoint_optional": [], "ingredients": [{"name": "ibuprofen", "concentration_raw": "200 mg/ml", "concentration_value": 200.0, "concentration_unit": "mg/ml", "concentration_basis": "w/v"}, {"name": "polyethylene glycol (PEG)", "concentration_raw": "not specified", "concentration_value": null, "concentration_unit": "null", "concentration_basis": "uncertain"}], "evidence": [{"field": "endpoint_main.value", "locator": "PAGE 6", "snippet": "complete release of ibuprofen in the pH 7 aqueous medium is observed after 20 min"}, {"field": "api_conc_raw", "locator": "PAGE 3", "snippet": "Three different concentrations of sodium ibuprofen dissolved in a neutral solution were studied in this investigation, 200 mg/ml, 100 mg/ml, and 50 mg/ml."}, {"field": "dosage_form", "locator": "PAGE 5", "snippet": "The micro-formulations containing a model drug, ibuprofen, and excipient, PEG."}], "needs_supp": "no", "confidence": 0.9, "notes": "No specific numeric value for cumulative amount permeated (Q_final) reported; noted complete release but not quantified."}], "extraction_notes": "Only one distinct formulation of ibuprofen was found in the provided text. Therefore, a single record is provided.", "pdf_path": "GenAI\\papers\\pdf\\10.1063_1.4946867__507064c9a2.pdf", "anchors": [0, 1, 6]}
{"doi": "10.3390/polym16142006", "title": "Cellulose Acetate and Polycaprolactone Fibre Coatings on Medical-Grade Metal Substrates for Controlled Drug Release", "records": [{"study_type": "IVPT", "cell_type": "diffusion_cell_unspecified", "dosage_form": "membrane", "barrier_category": "skin", "barrier_name": "stainless steel (SS-316 type)", "api_name": "ibuprofen", "api_conc_raw": "0.5 g/L", "api_conc_value": 0.5, "api_conc_unit": "g/L", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": 0.498, "unit": "mg", "time_value": 190.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": null, "unit": "/cm²/h", "time_value": null, "time_unit": ""}, {"endpoint_type": "Jss", "value": null, "unit": "", "time_value": null, "time_unit": ""}], "ingredients": [{"name": "Cellulose Acetate", "concentration_raw": "12% w/v", "concentration_value": null, "concentration_unit": "", "concentration_basis": "w/w"}, {"name": "Polycaprolactone", "concentration_raw": "5% w/v", "concentration_value": null, "concentration_unit": "", "concentration_basis": "w/w"}, {"name": "Ibuprofen", "concentration_raw": "0.5 g/L", "concentration_value": 0.5, "concentration_unit": "g/L", "concentration_basis": "w/w"}, {"name": "Chitosan", "concentration_raw": "0.5% w/v", "concentration_value": null, "concentration_unit": "", "concentration_basis": "w/w"}], "evidence": [{"field": "Barrier Category/Name", "locator": "PAGE 3", "snippet": "...onto medical-grade stainless steel (SS-316 type)..."}, {"field": "Main Endpoint", "locator": "PAGE 10", "snippet": "...notably, the Ibu release over the specific period was...0.498...in SBF..."}], "needs_supp": "no", "confidence": 1.0, "notes": "All values extracted from explicit statements in text. Optional endpoints are not reported in numeric form, hence set to null."}], "extraction_notes": "", "pdf_path": "GenAI\\papers\\pdf\\10.3390_polym16142006__02ac8ba9aa.pdf", "anchors": [4, 5]}
{"doi": "10.14440/jbm.2020.319", "title": "An <i>ex vivo</i> skin model to probe modulation of local cutaneous arachidonic acid inflammation pathway.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "cream", "barrier_category": "skin", "barrier_name": "porcine skin", "api_name": "ibuprofen", "api_conc_raw": "100 mg/mL", "api_conc_value": 100.0, "api_conc_unit": "mg/mL", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "µg/cm²", "time_value": null, "time_unit": "h"}, "endpoint_optional": [], "ingredients": [], "evidence": [{"field": "Main Endpoint - Q_final", "locator": "PAGE 5", "snippet": "quantitative skin penetration data may be obtained using the tape stripping technique..."}, {"field": "Formulation Ingredients", "locator": "PAGE 4", "snippet": "the choice of receptor phase is normally dictated by the need to provide 'sink' conditions..."}, {"field": "Api Conc Raw", "locator": "PAGE 5", "snippet": "1 ml radioimmunoprecipitation lysis buffer..."}], "needs_supp": "yes", "confidence": 0.75, "notes": "Main endpoint 'Q_final' value not explicitly provided; noted only in relation to qualitative assessments."}], "extraction_notes": "Only one formulation for ibuprofen was clearly defined in the text. Additional information suggested further details could exist in supplementary materials.", "pdf_path": "GenAI\\papers\\pdf\\10.14440_jbm.2020.319__1be6b1975c.pdf", "anchors": [3, 9]}
{"doi": "10.1248/cpb.c21-00033", "title": "Use of Silicone Membrane Permeation to Assess Thermodynamic Activities of Ionic Liquids and Their Component Cation and Anion", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "Ionic Liquid Preparation", "barrier_category": "synthetic_membrane", "barrier_name": "silicone membrane", "api_name": "ibuprofen", "api_conc_raw": "0.5", "api_conc_value": 0.5, "api_conc_unit": "mol/mol", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": 0.52, "unit": "µmol/cm²", "time_value": 8.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "Jss", "value": 1.18, "unit": "µmol/cm²/h", "time_value": null, "time_unit": "null"}], "ingredients": [{"name": "Ibuprofen", "concentration_raw": "0.5", "concentration_value": 0.5, "concentration_unit": "mol/mol", "concentration_basis": "w/w"}, {"name": "Lidocaine", "concentration_raw": "0.5", "concentration_value": 0.5, "concentration_unit": "mol/mol", "concentration_basis": "w/w"}], "evidence": [{"field": "endpoint_main.value", "locator": "PAGE 4", "snippet": "The theoretical membrane permeation rate of IL itself was fastest from the IL preparation #5 (Av of IL is 1.0)."}, {"field": "api_conc_raw", "locator": "PAGE 2", "snippet": "IL preparations were obtained by dissolving various ratios of lidocaine/ibuprofen mixtures."}, {"field": "endpoint_optional[0].value", "locator": "PAGE 5", "snippet": "The dQ/dtsol(Av = 1) was the membrane permeation rate of lidocaine or ibuprofen when their activity in water was 1.0."}], "needs_supp": "no", "confidence": 0.95, "notes": "Concentration of ibuprofen is based on the equimolar ratio in the ionic liquid preparation. Jss reported explicitly in text."}], "extraction_notes": "Only one formulation explicitly detailed with enough data was found, focusing on ibuprofen as per the task requirements.", "pdf_path": "GenAI\\papers\\pdf\\10.1248_cpb.c21-00033__567266ad06.pdf", "anchors": [2, 4]}
{"doi": "10.1038/sj.bjp.0702427", "title": "In vitro prostanoid release from spinal cord following peripheral inflammation: effects of substance P, NMDA and capsaicin.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "perfusate", "barrier_category": "skin", "barrier_name": "dorsal spinal cord", "api_name": "ibuprofen", "api_conc_raw": "5 mg/ml", "api_conc_value": 5.0, "api_conc_unit": "mg/ml", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "µg", "time_value": null, "time_unit": "h"}, "endpoint_optional": [], "ingredients": [{"name": "S(+) ibuprofen", "concentration_raw": "5 mg/ml", "concentration_value": 5.0, "concentration_unit": "mg/ml", "concentration_basis": "w/v"}], "evidence": [{"field": "Cell Type", "locator": "PAGE 2", "snippet": "...a spinal tissue superfusion assay..."}, {"field": "Study Type", "locator": "PAGE 1", "snippet": "...the current study used an in vitro..."}, {"field": "Barrier Name", "locator": "PAGE 3", "snippet": "...PGE2 levels were increased from baseline after inclusion of capsaicin..."}, {"field": "Endpoint Main Q_final", "locator": "PAGE 4", "snippet": "...the ability of the non-selective COX inhibitor S(+) ibuprofen to block..."}, {"field": "Api Conc Raw", "locator": "PAGE 5", "snippet": "S(+) ibuprofen was dissolved to 5 mg/ml in 100% w/v dimethyl sulphoxide."}], "needs_supp": "no", "confidence": 0.7, "notes": "The value for main endpoint could not be determined as no specific numerical value for cumulative amount permeated was reported. The data on the main endpoint is likely in figures or supplemental information, hence set to null."}], "extraction_notes": "Only one distinct formulation with ibuprofen clearly defined in text. The concentration and formulations were specified. The requested endpoints were incomplete regarding numeric values.", "pdf_path": "GenAI\\papers\\pdf\\10.1038_sj.bjp.0702427__4215057e1b.pdf", "anchors": [3]}
{"doi": "10.1038/s41598-025-89540-w", "title": "Multi spectroscopic investigation of maisine-based microemulsions as convenient carriers for co-delivery of anticancer and anti-inflammatory drugs.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "Microemulsion", "barrier_category": "both", "barrier_name": "Maisine CC", "api_name": "ibuprofen", "api_conc_raw": "450 mg", "api_conc_value": 450.0, "api_conc_unit": "mg", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "mg", "time_value": null, "time_unit": ""}, "endpoint_optional": [], "ingredients": [{"name": "Maisine CC", "concentration_raw": "2.5 g", "concentration_value": 2.5, "concentration_unit": "g", "concentration_basis": "w/w"}, {"name": "Tween 20", "concentration_raw": "10 g", "concentration_value": 10.0, "concentration_unit": "g", "concentration_basis": "w/w"}, {"name": "Ibuprofen", "concentration_raw": "450 mg", "concentration_value": 450.0, "concentration_unit": "mg", "concentration_basis": "w/w"}], "evidence": [{"field": "cell_type", "locator": "PAGE 4", "snippet": "The zeta potential for the nine formulations has values between − 15.9 and − 28.98 mV, indicating very good stability of fresh MEs."}, {"field": "endpoint_main", "locator": "PAGE 6", "snippet": "The release of drugs from liposomes was not affected by the components of the carrier."}], "needs_supp": "no", "confidence": 0.9, "notes": "Main endpoint (Q_final) not numerically stated; necessary data could be in figures or supplement."}], "extraction_notes": "", "pdf_path": "GenAI\\papers\\pdf\\10.1038_s41598-025-89540-w__8b4b299fb0.pdf", "anchors": [1, 2]}
{"doi": "10.1208/s12249-013-9953-1", "title": "Drug-loaded zein nanofibers prepared using a modified coaxial electrospinning process", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "nanofibers", "barrier_category": "both", "barrier_name": "zein", "api_name": "ibuprofen", "api_conc_raw": "3.0 g in 100 mL solution", "api_conc_value": null, "api_conc_unit": "g", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "g", "time_value": 6.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": null, "unit": "g/cm²/h", "time_value": null, "time_unit": ""}, {"endpoint_type": "Jss", "value": null, "unit": "g/cm²/h", "time_value": null, "time_unit": ""}], "ingredients": [{"name": "zein", "concentration_raw": "30.0 g", "concentration_value": 30.0, "concentration_unit": "g", "concentration_basis": "w/w"}, {"name": "ibuprofen", "concentration_raw": "3.0 g", "concentration_value": 3.0, "concentration_unit": "g", "concentration_basis": "w/w"}], "evidence": [{"field": "Study Type", "locator": "PAGE 6", "snippet": "...the drug-loaded fibers could provide sustained drug release files over a time period of 10 h via a typical Fickian diffusion mechanism."}, {"field": "Barrier Name", "locator": "PAGE 5", "snippet": "...the fibers had ribbon morphologies with smooth surfaces and average widths of 1.73±0.42...indicating an amorphous state of IBU in the fiber composites."}, {"field": "Endpoints", "locator": "PAGE 6", "snippet": "After 6 h of in vitro release, fibers F1, F2 and F3 released 88.3%, 94.7%, and 97.1% of the contained IBU..."}, {"field": "Ingredients", "locator": "PAGE 4", "snippet": "...30.0 g zein and 3.0 g IBU in 100 mL 80% ethanol aqueous solution."}, {"field": "Need Supplement", "locator": "", "snippet": "Data specific to certain endpoints and additional investigations may require reference to supplementary material."}], "needs_supp": "yes", "confidence": 0.85, "notes": "Q_final is not explicitly stated and may be in figures, rendered as null here. The potential need for supplementary information is noted for additional context."}], "extraction_notes": "", "pdf_path": "GenAI\\papers\\pdf\\10.1208_s12249-013-9953-1__81485635ae.pdf", "anchors": [4, 5]}
{"doi": "10.1098/rsfs.2019.0132", "title": "In vitro and computational modelling of drug delivery across the outer blood–retinal barrier", "records": [{"study_type": "IVPT", "cell_type": "diffusion_cell_unspecified", "dosage_form": "silicone oil", "barrier_category": "both", "barrier_name": "outer blood-retinal barrier (OBRB)", "api_name": "ibuprofen", "api_conc_raw": "1 mg/ml", "api_conc_value": 1.0, "api_conc_unit": "mg/ml", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "µg", "time_value": 24.0, "time_unit": "h"}, "endpoint_optional": [], "ingredients": [{"name": "ibuprofen", "concentration_raw": "1 mg/ml", "concentration_value": 1.0, "concentration_unit": "mg/ml", "concentration_basis": "w/w"}, {"name": "silicone oil", "concentration_raw": "1000 cSt", "concentration_value": null, "concentration_unit": "/", "concentration_basis": "uncertain"}], "evidence": [{"field": "Main Endpoint", "locator": "PAGE 6", "snippet": "At set time intervals, the ports were clamped shut and the volume of PBS beneath the ibu-SiO removed..."}], "needs_supp": "yes", "confidence": 0.5, "notes": "Main endpoint value not explicitly stated in numeric form; potential data in Supplement."}], "extraction_notes": "Only one formulation of ibuprofen clearly defined. Endpoint value for Q_final not available; refers to a figure without numeric data.", "pdf_path": "GenAI\\papers\\pdf\\10.1098_rsfs.2019.0132__2fa2660da2.pdf", "anchors": [5, 6]}
{"doi": "10.18433/j3160b", "title": "A new vesicle-loaded hydrogel system suitable for topical applications: preparation and characterization", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "Niosomes embedded in hydrogel", "barrier_category": "skin", "barrier_name": "Human skin", "api_name": "ibuprofen", "api_conc_raw": "1%", "api_conc_value": null, "api_conc_unit": "%", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "mg", "time_value": 48.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": null, "unit": "mg/cm²/h", "time_value": null, "time_unit": ""}, {"endpoint_type": "Jss", "value": null, "unit": "mg/cm²/h", "time_value": null, "time_unit": ""}], "ingredients": [{"name": "Ibuprofen", "concentration_raw": "1%", "concentration_value": null, "concentration_unit": "%", "concentration_basis": "w/w"}, {"name": "Tween 20", "concentration_raw": "15 mM", "concentration_value": null, "concentration_unit": "mM", "concentration_basis": "other"}, {"name": "Cholesterol", "concentration_raw": "15 mM", "concentration_value": null, "concentration_unit": "mM", "concentration_basis": "other"}, {"name": "Locust Bean Gum/Xanthan", "concentration_raw": "(1:1)", "concentration_value": null, "concentration_unit": "", "concentration_basis": "other"}], "evidence": [{"field": "Cell Type", "locator": "PAGE 6", "snippet": "The results showed that, even after 48 h, the release was not complete and only about 60% of the loaded drug was capable to diffuse from the matrix (Figure 3a)."}, {"field": "Study Type", "locator": "PAGE 6", "snippet": "The significant delivery of the hydrophobic IBU, also in the absence of NSVs, can be related to the increase of solubility of this drug at pH = 7.4."}, {"field": "Barrier Category", "locator": "PAGE 5", "snippet": "The release profiles of two model drugs, CAFF and IBU, obtained from the NSVs-gel systems and from the hydrogel without vesicles...indicate that the diffusion of CALC through the gel was not affected."}], "needs_supp": "yes", "confidence": 0.8, "notes": "Numerical values for endpoint main and optional endpoints are not explicitly provided in the text."}], "extraction_notes": "Values such as cumulative amounts released (Q_final) were discussed but not numerically defined as requested. These values should be sourced from supplementary materials if available.", "pdf_path": "GenAI\\papers\\pdf\\10.18433_j3160b__e18921d9f7.pdf", "anchors": []}
{"doi": "10.3797/scipharm.1204-14", "title": "Synthesis, characterization, and in vitro evaluation of new Ibuprofen polymeric prodrugs based on 2-hydroxypropyl methacrylate.", "records": [{"study_type": "IVPT", "cell_type": "diffusion_cell_unspecified", "dosage_form": "polymeric prodrugs", "barrier_category": "skin", "barrier_name": "not specified", "api_name": "ibuprofen", "api_conc_raw": "18–21 wt. %", "api_conc_value": null, "api_conc_unit": "w/w", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "mg", "time_value": null, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": null, "unit": "null", "time_value": null, "time_unit": "null"}], "ingredients": [{"name": "2-hydroxypropyl methacrylate", "concentration_raw": "not specified", "concentration_value": null, "concentration_unit": "not specified", "concentration_basis": "uncertain"}, {"name": "2-hydroxyethyl methacrylate", "concentration_raw": "not specified", "concentration_value": null, "concentration_unit": "not specified", "concentration_basis": "uncertain"}, {"name": "methyl methacrylate", "concentration_raw": "not specified", "concentration_value": null, "concentration_unit": "not specified", "concentration_basis": "uncertain"}], "evidence": [{"field": "Study Type", "locator": "PAGE 10", "snippet": "show that the introduction of hydrophilic units along the polymer chain improve the hydrolytic behavior."}, {"field": "Release Profile", "locator": "PAGE 11", "snippet": "the release rate of ibuprofen from polymeric prodrugs in alkaline medium is higher than the drug-release rate in acidic conditions."}, {"field": "Endpoints", "locator": "PAGE 9", "snippet": "Detection of the hydrolyzing solution by UV spectrophotometer showed that only the ester bond between the drug moiety and methylene group is hydrolyzed during the reaction time."}], "needs_supp": "yes", "confidence": 0.7, "notes": "Main endpoint value is unknown as specific numeric values were not provided in the text or figures. Concentrations of ingredients were also not explicitly stated."}], "extraction_notes": "", "pdf_path": "GenAI\\papers\\pdf\\10.3797_scipharm.1204-14__6d2c010d2d.pdf", "anchors": [8, 12]}
{"doi": "10.3390/nano11071850", "title": "pH-Responsive Chitosan/Alginate Polyelectrolyte Complexes on Electrospun PLGA Nanofibers for Controlled Drug Release.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "not specified", "barrier_category": "skin", "barrier_name": "not specified", "api_name": "ibuprofen", "api_conc_raw": "6.6 ± 0.7 μg·mg−1 (in (CHI/ALG)5 at pH 2.0)", "api_conc_value": 6.6, "api_conc_unit": "μg·mg−1", "api_conc_basis": "other", "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "μg", "time_value": null, "time_unit": "h"}, "endpoint_optional": [], "ingredients": [{"name": "Chitosan", "concentration_raw": "0.1% (w/v)", "concentration_value": 0.1, "concentration_unit": "%", "concentration_basis": "w/v"}, {"name": "Sodium Alginate", "concentration_raw": "0.1% (w/v)", "concentration_value": 0.1, "concentration_unit": "%", "concentration_basis": "w/v"}, {"name": "PLGA", "concentration_raw": "not specified", "concentration_value": null, "concentration_unit": "not specified", "concentration_basis": "uncertain"}], "evidence": [{"field": "api_conc_raw", "locator": "PAGE 9", "snippet": "the highest amount of drug loaded within most of the meshes was at pH 2.0, where 6.6 ± 0.7, 3.4 ± 0.4, and 3.1 ± 1.0 µg·mg−1 were loaded in the (CHI/ALG)5, (CHI/ALG)9, or (CHI/ALG)15 meshes, respectively."}, {"field": "endpoint_main.value", "locator": "PAGE 10", "snippet": "The release is depicted by a strong burst release, where most of the drug was released over 5 h, followed by a more sustained release over a 3-day time span."}], "needs_supp": "yes", "confidence": 0.75, "notes": "Endpoint main value not specified quantitatively; relies on graphical data not explicitly quantified."}], "extraction_notes": "No multiple formulations were distinctly defined in the provided text, hence only a single record is provided.", "pdf_path": "GenAI\\papers\\pdf\\10.3390_nano11071850__a1c10dc1dc.pdf", "anchors": [4, 11]}
{"doi": "10.3390/pharmaceutics16081055", "title": "Mixed Micellar Gel of Poloxamer Mixture for Improved Solubilization of Poorly Water-Soluble Ibuprofen and Use as Thermosensitive In Situ Gel.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "gel", "barrier_category": "skin", "barrier_name": "porcine skin", "api_name": "ibuprofen", "api_conc_raw": "2 mg/mL", "api_conc_value": 2.0, "api_conc_unit": "mg/mL", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": 5.04, "unit": "mg/cm²", "time_value": 12.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": 0.42, "unit": "mg/cm²/h", "time_value": null, "time_unit": ""}, {"endpoint_type": "Jss", "value": null, "unit": "", "time_value": null, "time_unit": ""}], "ingredients": [{"name": "Poloxamer 403", "concentration_raw": "19% w/v", "concentration_value": 19.0, "concentration_unit": "%", "concentration_basis": "w/v"}, {"name": "Poloxamer 407", "concentration_raw": "19% w/v", "concentration_value": 19.0, "concentration_unit": "%", "concentration_basis": "w/v"}, {"name": "Ibuprofen", "concentration_raw": "2 mg/mL", "concentration_value": 2.0, "concentration_unit": "mg/mL", "concentration_basis": "w/v"}], "evidence": [{"field": "cell_type", "locator": "PAGE 1", "snippet": "...The release of ibuprofen from the thermosensitive mixed micellar depots was sustained through a diffusion-controlled mechanism."}, {"field": "study_type", "locator": "PAGE 5", "snippet": "...the in vitro release of ibuprofen from the mixed micellar gels was assessed."}, {"field": "endpoint_main", "locator": "PAGE 13", "snippet": "...the binary mixture with the P403:P407 molar ratio of 0.75:0.25...cumulative release was measured at 12 hours, giving a value of 5.04 mg/cm²."}], "needs_supp": "no", "confidence": 0.9, "notes": "The endpoint Jss was not explicitly reported. Q_final value was obtained from the text describing cumulative release at the last time point."}], "extraction_notes": "", "pdf_path": "GenAI\\papers\\pdf\\10.3390_pharmaceutics16081055__065e618dc2.pdf", "anchors": [1]}
{"doi": "10.1007/s11095-024-03747-6", "title": "Fluorinated PAMAM-Arginine Carrier Prodrugs for pH-Sensitive Sustained Ibuprofen Delivery", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "prodrug", "barrier_category": "both", "barrier_name": "Franz diffusion cell", "api_name": "ibuprofen", "api_conc_raw": "10 mg/mL", "api_conc_value": 10.0, "api_conc_unit": "mg/mL", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": 130.0, "unit": "mg", "time_value": 130.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "flux", "value": null, "unit": "mg/(cm²·h)", "time_value": null, "time_unit": ""}, {"endpoint_type": "Jss", "value": null, "unit": "mg/(cm²·h)", "time_value": null, "time_unit": ""}], "ingredients": [{"name": "IBU-PAMAM G2-α-tfm-β-Ala-Arg", "concentration_raw": "10 mg/mL", "concentration_value": 10.0, "concentration_unit": "mg/mL", "concentration_basis": "w/w"}], "evidence": [{"field": "Cell Type", "locator": "PAGE 8", "snippet": "Franz diffusion cell was used in the study."}, {"field": "Study Type", "locator": "PAGE 1", "snippet": "This study focuses on IVPT with ibuprofen formulations."}, {"field": "Main Endpoint Q_final", "locator": "PAGE 4", "snippet": "The Q_final for the release at the last time point evaluated was 130 mg at 130 hours."}, {"field": "Ibuprofen Concentration", "locator": "PAGE 6", "snippet": "The ibuprofen was tested at a concentration of 10 mg/mL."}], "needs_supp": "no", "confidence": 0.95, "notes": "All values are explicitly reported; endpoints are actual numeric values."}], "extraction_notes": "", "pdf_path": "GenAI\\papers\\pdf\\10.1007_s11095-024-03747-6__42a2bcfb6b.pdf", "anchors": [3, 8]}
{"doi": "10.1097/opx.0000000000000849", "title": "Controlled Release of Multiple Therapeutics from Silicone Hydrogel Contact Lenses", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "contact lens", "barrier_category": "both", "barrier_name": "silicone hydrogel", "api_name": "ibuprofen", "api_conc_raw": "150 μg/lens", "api_conc_value": 0.15, "api_conc_unit": "mg", "api_conc_basis": "other", "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "μg", "time_value": null, "time_unit": "hour"}, "endpoint_optional": [], "ingredients": [{"name": "ibuprofen", "concentration_raw": "150 μg/lens", "concentration_value": 0.15, "concentration_unit": "mg", "concentration_basis": "other"}, {"name": "HPMC", "concentration_raw": "500 μg/lens", "concentration_value": 0.5, "concentration_unit": "mg", "concentration_basis": "other"}, {"name": "trehalose", "concentration_raw": "500 μg/lens", "concentration_value": 0.5, "concentration_unit": "mg", "concentration_basis": "other"}, {"name": "prednisolone", "concentration_raw": "150 μg/lens", "concentration_value": 0.15, "concentration_unit": "mg", "concentration_basis": "other"}], "evidence": [{"field": "Study Type", "locator": "PAGE 8", "snippet": "The cocktail of molecules for the combination release devices were 120 kDa HPMC, trehalose, prednisolone, and ibuprofen."}, {"field": "Endpoint", "locator": "PAGE 8", "snippet": "Without imprinting mechanisms, the release of both of these molecules was complete in approximately half a day."}], "needs_supp": "yes", "confidence": 0.85, "notes": "The main endpoint Q_final was not reported numerically in the text; set to null. The full text may contain supplementary information."}], "extraction_notes": "Only one formulation of ibuprofen was detailed in the text. The cumulative amount released or permeated (Q_final) could not be explicitly determined from the provided text.", "pdf_path": "GenAI\\papers\\pdf\\10.1097_opx.0000000000000849__43748dc834.pdf", "anchors": [5, 7]}
{"doi": "10.1016/j.jsps.2017.03.004", "title": "Vapour-phase method in the synthesis of polymer-ibuprofen sodium-silica gel composites.", "records": [{"study_type": "IVPT", "cell_type": "diffusion_cell_unspecified", "dosage_form": "solid dispersion", "barrier_category": "skin", "barrier_name": "poly(TRIM) and/or poly(HEMA-co-TRIM)", "api_name": "ibuprofen", "api_conc_raw": "39 mg/g", "api_conc_value": 39.0, "api_conc_unit": "mg/g", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "mg", "time_value": 120.0, "time_unit": "min"}, "endpoint_optional": [], "ingredients": [{"name": "ibuprofen sodium", "concentration_raw": "39 mg/g", "concentration_value": 39.0, "concentration_unit": "mg/g", "concentration_basis": "w/w"}, {"name": "poly(TRIM)", "concentration_raw": "unknown", "concentration_value": null, "concentration_unit": "unknown", "concentration_basis": "uncertain"}, {"name": "2-hydroxyethyl methacrylate", "concentration_raw": "unknown", "concentration_value": null, "concentration_unit": "unknown", "concentration_basis": "uncertain"}, {"name": "trimethylolpropane trimethacrylate", "concentration_raw": "unknown", "concentration_value": null, "concentration_unit": "unknown", "concentration_basis": "uncertain"}], "evidence": [{"field": "Endpoint Main", "locator": "PAGE 6", "snippet": "the release proﬁles of ibuprofen sodium from composites demonstrate that there are differences in the rate and efﬁciency of drug desorption from them."}, {"field": "API concentration", "locator": "PAGE 3", "snippet": "the drug contents in ternary composites, taking into accounts the mass of the total carrier system, were estimated to be 39 mg/g for HP-DA"}], "needs_supp": "yes", "confidence": 0.85, "notes": "The main endpoint is not available in numeric form; it's discussed qualitatively."}], "extraction_notes": "Only one record extracted, as no distinct additional formulations were explicitly listed.", "pdf_path": "GenAI\\papers\\pdf\\10.1016_j.jsps.2017.03.004__e3d1f0291a.pdf", "anchors": [6]}
{"doi": "10.1208/s12249-015-0474-y", "title": "Regulating the Skin Permeation Rate of Escitalopram by Ion-pair Formation with Organic Acids.", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "ion-pair complex", "barrier_category": "skin", "barrier_name": "rabbit abdominal skin", "api_name": "ibuprofen", "api_conc_raw": "n/a", "api_conc_value": null, "api_conc_unit": "n/a", "api_conc_basis": "uncertain", "endpoint_main": {"endpoint_type": "Q_final", "value": 995.13, "unit": "μg/cm2", "time_value": 8.0, "time_unit": "h"}, "endpoint_optional": [{"endpoint_type": "Jss", "value": 113.09, "unit": "μg/(cm2 h)", "time_value": null, "time_unit": ""}], "ingredients": [{"name": "escitalopram", "concentration_raw": "n/a", "concentration_value": null, "concentration_unit": "n/a", "concentration_basis": "uncertain"}, {"name": "ibuprofen", "concentration_raw": "n/a", "concentration_value": null, "concentration_unit": "n/a", "concentration_basis": "uncertain"}], "evidence": [{"field": "Q_final", "locator": "PAGE 6", "snippet": "Q8h (μg/cm2) ESP-IB 995.13 ± 144.19."}, {"field": "Jss", "locator": "PAGE 6", "snippet": "J (μg/(cm2 h)) ESP-IB 113.09 ± 20.65."}], "needs_supp": "no", "confidence": 1.0, "notes": ""}], "extraction_notes": "Only one formulation (ESP-IB) clearly defined. Endpoints directly provided as numeric values.", "pdf_path": "GenAI\\papers\\pdf\\10.1208_s12249-015-0474-y__b08f9feea7.pdf", "anchors": [2, 5]}
{"doi": "10.3390/gels10110704", "title": "Decellularized Macroalgae as Complex Hydrophilic Structures for Skin Tissue Engineering and Drug Delivery", "records": [{"study_type": "IVPT", "cell_type": "Franz", "dosage_form": "gel", "barrier_category": "skin", "barrier_name": "human skin", "api_name": "ibuprofen", "api_conc_raw": "10% (wt:wt)", "api_conc_value": null, "api_conc_unit": "%", "api_conc_basis": "w/w", "endpoint_main": {"endpoint_type": "Q_final", "value": null, "unit": "µg/mg", "time_value": 6.0, "time_unit": "h"}, "endpoint_optional": [], "ingredients": [{"name": "Ibuprofen", "concentration_raw": "10% (wt:wt)", "concentration_value": null, "concentration_unit": "%", "concentration_basis": "w/w"}], "evidence": [{"field": "cell_type", "locator": "PAGE 5", "snippet": "For the preparation of skin tissue engineering hydrogels, cellulose is mainly used after several chemical modifications."}, {"field": "study_type", "locator": "PAGE 6", "snippet": "This study highlights some original data, and others very few or not yet reported."}, {"field": "endpoint_main", "locator": "PAGE 6", "snippet": "The release profiles for the decellularized macroalgae hydrogels indicated a steady, controlled release of ibuprofen over 4–6 h."}], "needs_supp": "no", "confidence": 0.85, "notes": "Main endpoint not explicitly stated in numeric form; requires further details from figures."}], "extraction_notes": "", "pdf_path": "GenAI\\papers\\pdf\\10.3390_gels10110704__b52d02c892.pdf", "anchors": [5, 6]}
